00017246702021Q3FALSE--04-02P3Y00017246702020-04-012021-01-01xbrli:shares00017246702021-01-29iso4217:USD00017246702020-10-032021-01-0100017246702019-10-012019-12-3100017246702019-04-012019-12-31iso4217:USDxbrli:shares00017246702021-01-0100017246702020-03-310001724670us-gaap:CommonStockMember2020-03-310001724670us-gaap:AdditionalPaidInCapitalMember2020-03-310001724670us-gaap:RetainedEarningsMember2020-03-310001724670us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-310001724670us-gaap:TreasuryStockMember2020-03-310001724670us-gaap:RetainedEarningsMember2020-04-012020-07-0300017246702020-04-012020-07-030001724670us-gaap:AdditionalPaidInCapitalMember2020-04-012020-07-030001724670us-gaap:CommonStockMember2020-04-012020-07-030001724670us-gaap:TreasuryStockMember2020-04-012020-07-030001724670us-gaap:CommonStockMember2020-07-030001724670us-gaap:AdditionalPaidInCapitalMember2020-07-030001724670us-gaap:RetainedEarningsMember2020-07-030001724670us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-07-030001724670us-gaap:TreasuryStockMember2020-07-0300017246702020-07-030001724670us-gaap:RetainedEarningsMember2020-07-042020-10-0200017246702020-07-042020-10-020001724670us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-07-042020-10-020001724670us-gaap:AdditionalPaidInCapitalMember2020-07-042020-10-020001724670us-gaap:CommonStockMember2020-07-042020-10-020001724670us-gaap:CommonStockMember2020-10-020001724670us-gaap:AdditionalPaidInCapitalMember2020-10-020001724670us-gaap:RetainedEarningsMember2020-10-020001724670us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-10-020001724670us-gaap:TreasuryStockMember2020-10-0200017246702020-10-020001724670us-gaap:RetainedEarningsMember2020-10-032021-01-010001724670us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-10-032021-01-010001724670us-gaap:AdditionalPaidInCapitalMember2020-10-032021-01-010001724670us-gaap:CommonStockMember2020-10-032021-01-010001724670us-gaap:CommonStockMember2021-01-010001724670us-gaap:AdditionalPaidInCapitalMember2021-01-010001724670us-gaap:RetainedEarningsMember2021-01-010001724670us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-010001724670us-gaap:TreasuryStockMember2021-01-010001724670us-gaap:CommonStockMember2019-03-310001724670us-gaap:AdditionalPaidInCapitalMember2019-03-310001724670us-gaap:RetainedEarningsMember2019-03-310001724670us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-03-310001724670us-gaap:TreasuryStockMember2019-03-3100017246702019-03-310001724670us-gaap:RetainedEarningsMember2019-04-012019-06-3000017246702019-04-012019-06-300001724670us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-04-012019-06-300001724670us-gaap:AdditionalPaidInCapitalMember2019-04-012019-06-300001724670us-gaap:TreasuryStockMember2019-04-012019-06-300001724670us-gaap:CommonStockMember2019-04-012019-06-300001724670us-gaap:CommonStockMember2019-06-300001724670us-gaap:AdditionalPaidInCapitalMember2019-06-300001724670us-gaap:RetainedEarningsMember2019-06-300001724670us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-06-300001724670us-gaap:TreasuryStockMember2019-06-3000017246702019-06-300001724670us-gaap:RetainedEarningsMember2019-07-012019-09-3000017246702019-07-012019-09-300001724670us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-07-012019-09-300001724670us-gaap:AdditionalPaidInCapitalMember2019-07-012019-09-300001724670us-gaap:TreasuryStockMember2019-07-012019-09-300001724670us-gaap:CommonStockMember2019-07-012019-09-300001724670us-gaap:CommonStockMember2019-09-300001724670us-gaap:AdditionalPaidInCapitalMember2019-09-300001724670us-gaap:RetainedEarningsMember2019-09-300001724670us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-09-300001724670us-gaap:TreasuryStockMember2019-09-3000017246702019-09-300001724670us-gaap:RetainedEarningsMember2019-10-012019-12-310001724670us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-10-012019-12-310001724670us-gaap:AdditionalPaidInCapitalMember2019-10-012019-12-310001724670us-gaap:TreasuryStockMember2019-10-012019-12-310001724670us-gaap:CommonStockMember2019-10-012019-12-310001724670us-gaap:CommonStockMember2019-12-310001724670us-gaap:AdditionalPaidInCapitalMember2019-12-310001724670us-gaap:RetainedEarningsMember2019-12-310001724670us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310001724670us-gaap:TreasuryStockMember2019-12-3100017246702019-12-31prsp:facility0001724670prsp:DHPCTechnologiesMember2020-05-012020-05-010001724670prsp:DHPCTechnologiesMember2020-05-010001724670prsp:DHPCTechnologiesMemberprsp:ProgramAssetsMember2020-05-012020-05-010001724670prsp:DHPCTechnologiesMemberus-gaap:OrderOrProductionBacklogMember2020-05-012020-05-010001724670prsp:DHPCTechnologiesMemberprsp:ProgramAssetsMembersrt:MinimumMember2020-05-012020-05-010001724670prsp:KnightPointSystemsLLCMember2019-07-312019-07-310001724670prsp:CostreimbursableContractMemberprsp:DefenseAndIntelligenceSegmentMember2020-10-032021-01-010001724670prsp:CostreimbursableContractMemberprsp:CivilianAndHealthCareSegmentMember2020-10-032021-01-010001724670prsp:CostreimbursableContractMember2020-10-032021-01-010001724670prsp:CostreimbursableContractMemberprsp:DefenseAndIntelligenceSegmentMember2019-10-012019-12-310001724670prsp:CostreimbursableContractMemberprsp:CivilianAndHealthCareSegmentMember2019-10-012019-12-310001724670prsp:CostreimbursableContractMember2019-10-012019-12-310001724670us-gaap:FixedPriceContractMemberprsp:DefenseAndIntelligenceSegmentMember2020-10-032021-01-010001724670us-gaap:FixedPriceContractMemberprsp:CivilianAndHealthCareSegmentMember2020-10-032021-01-010001724670us-gaap:FixedPriceContractMember2020-10-032021-01-010001724670us-gaap:FixedPriceContractMemberprsp:DefenseAndIntelligenceSegmentMember2019-10-012019-12-310001724670us-gaap:FixedPriceContractMemberprsp:CivilianAndHealthCareSegmentMember2019-10-012019-12-310001724670us-gaap:FixedPriceContractMember2019-10-012019-12-310001724670prsp:DefenseAndIntelligenceSegmentMemberus-gaap:TimeAndMaterialsContractMember2020-10-032021-01-010001724670us-gaap:TimeAndMaterialsContractMemberprsp:CivilianAndHealthCareSegmentMember2020-10-032021-01-010001724670us-gaap:TimeAndMaterialsContractMember2020-10-032021-01-010001724670prsp:DefenseAndIntelligenceSegmentMemberus-gaap:TimeAndMaterialsContractMember2019-10-012019-12-310001724670us-gaap:TimeAndMaterialsContractMemberprsp:CivilianAndHealthCareSegmentMember2019-10-012019-12-310001724670us-gaap:TimeAndMaterialsContractMember2019-10-012019-12-310001724670prsp:DefenseAndIntelligenceSegmentMember2020-10-032021-01-010001724670prsp:CivilianAndHealthCareSegmentMember2020-10-032021-01-010001724670prsp:DefenseAndIntelligenceSegmentMember2019-10-012019-12-310001724670prsp:CivilianAndHealthCareSegmentMember2019-10-012019-12-310001724670prsp:CostreimbursableContractMemberprsp:DefenseAndIntelligenceSegmentMember2020-04-012021-01-010001724670prsp:CostreimbursableContractMemberprsp:CivilianAndHealthCareSegmentMember2020-04-012021-01-010001724670prsp:CostreimbursableContractMember2020-04-012021-01-010001724670prsp:CostreimbursableContractMemberprsp:DefenseAndIntelligenceSegmentMember2019-04-012019-12-310001724670prsp:CostreimbursableContractMemberprsp:CivilianAndHealthCareSegmentMember2019-04-012019-12-310001724670prsp:CostreimbursableContractMember2019-04-012019-12-310001724670us-gaap:FixedPriceContractMemberprsp:DefenseAndIntelligenceSegmentMember2020-04-012021-01-010001724670us-gaap:FixedPriceContractMemberprsp:CivilianAndHealthCareSegmentMember2020-04-012021-01-010001724670us-gaap:FixedPriceContractMember2020-04-012021-01-010001724670us-gaap:FixedPriceContractMemberprsp:DefenseAndIntelligenceSegmentMember2019-04-012019-12-310001724670us-gaap:FixedPriceContractMemberprsp:CivilianAndHealthCareSegmentMember2019-04-012019-12-310001724670us-gaap:FixedPriceContractMember2019-04-012019-12-310001724670prsp:DefenseAndIntelligenceSegmentMemberus-gaap:TimeAndMaterialsContractMember2020-04-012021-01-010001724670us-gaap:TimeAndMaterialsContractMemberprsp:CivilianAndHealthCareSegmentMember2020-04-012021-01-010001724670us-gaap:TimeAndMaterialsContractMember2020-04-012021-01-010001724670prsp:DefenseAndIntelligenceSegmentMemberus-gaap:TimeAndMaterialsContractMember2019-04-012019-12-310001724670us-gaap:TimeAndMaterialsContractMemberprsp:CivilianAndHealthCareSegmentMember2019-04-012019-12-310001724670us-gaap:TimeAndMaterialsContractMember2019-04-012019-12-310001724670prsp:DefenseAndIntelligenceSegmentMember2020-04-012021-01-010001724670prsp:CivilianAndHealthCareSegmentMember2020-04-012021-01-010001724670prsp:DefenseAndIntelligenceSegmentMember2019-04-012019-12-310001724670prsp:CivilianAndHealthCareSegmentMember2019-04-012019-12-310001724670prsp:PrimeContractorMemberprsp:DefenseAndIntelligenceSegmentMember2020-10-032021-01-010001724670prsp:PrimeContractorMemberprsp:CivilianAndHealthCareSegmentMember2020-10-032021-01-010001724670prsp:PrimeContractorMember2020-10-032021-01-010001724670prsp:PrimeContractorMemberprsp:DefenseAndIntelligenceSegmentMember2019-10-012019-12-310001724670prsp:PrimeContractorMemberprsp:CivilianAndHealthCareSegmentMember2019-10-012019-12-310001724670prsp:PrimeContractorMember2019-10-012019-12-310001724670prsp:SubcontractorMemberprsp:DefenseAndIntelligenceSegmentMember2020-10-032021-01-010001724670prsp:SubcontractorMemberprsp:CivilianAndHealthCareSegmentMember2020-10-032021-01-010001724670prsp:SubcontractorMember2020-10-032021-01-010001724670prsp:SubcontractorMemberprsp:DefenseAndIntelligenceSegmentMember2019-10-012019-12-310001724670prsp:SubcontractorMemberprsp:CivilianAndHealthCareSegmentMember2019-10-012019-12-310001724670prsp:SubcontractorMember2019-10-012019-12-310001724670prsp:PrimeContractorMemberprsp:DefenseAndIntelligenceSegmentMember2020-04-012021-01-010001724670prsp:PrimeContractorMemberprsp:CivilianAndHealthCareSegmentMember2020-04-012021-01-010001724670prsp:PrimeContractorMember2020-04-012021-01-010001724670prsp:PrimeContractorMemberprsp:DefenseAndIntelligenceSegmentMember2019-04-012019-12-310001724670prsp:PrimeContractorMemberprsp:CivilianAndHealthCareSegmentMember2019-04-012019-12-310001724670prsp:PrimeContractorMember2019-04-012019-12-310001724670prsp:SubcontractorMemberprsp:DefenseAndIntelligenceSegmentMember2020-04-012021-01-010001724670prsp:SubcontractorMemberprsp:CivilianAndHealthCareSegmentMember2020-04-012021-01-010001724670prsp:SubcontractorMember2020-04-012021-01-010001724670prsp:SubcontractorMemberprsp:DefenseAndIntelligenceSegmentMember2019-04-012019-12-310001724670prsp:SubcontractorMemberprsp:CivilianAndHealthCareSegmentMember2019-04-012019-12-310001724670prsp:SubcontractorMember2019-04-012019-12-310001724670prsp:DefenseAndIntelligenceSegmentMemberprsp:FederalCustomersMember2020-10-032021-01-010001724670prsp:FederalCustomersMemberprsp:CivilianAndHealthCareSegmentMember2020-10-032021-01-010001724670prsp:FederalCustomersMember2020-10-032021-01-010001724670prsp:DefenseAndIntelligenceSegmentMemberprsp:FederalCustomersMember2019-10-012019-12-310001724670prsp:FederalCustomersMemberprsp:CivilianAndHealthCareSegmentMember2019-10-012019-12-310001724670prsp:FederalCustomersMember2019-10-012019-12-310001724670prsp:DefenseAndIntelligenceSegmentMemberprsp:NonFederalCustomersMember2020-10-032021-01-010001724670prsp:CivilianAndHealthCareSegmentMemberprsp:NonFederalCustomersMember2020-10-032021-01-010001724670prsp:NonFederalCustomersMember2020-10-032021-01-010001724670prsp:DefenseAndIntelligenceSegmentMemberprsp:NonFederalCustomersMember2019-10-012019-12-310001724670prsp:CivilianAndHealthCareSegmentMemberprsp:NonFederalCustomersMember2019-10-012019-12-310001724670prsp:NonFederalCustomersMember2019-10-012019-12-310001724670prsp:DefenseAndIntelligenceSegmentMemberprsp:FederalCustomersMember2020-04-012021-01-010001724670prsp:FederalCustomersMemberprsp:CivilianAndHealthCareSegmentMember2020-04-012021-01-010001724670prsp:FederalCustomersMember2020-04-012021-01-010001724670prsp:DefenseAndIntelligenceSegmentMemberprsp:FederalCustomersMember2019-04-012019-12-310001724670prsp:FederalCustomersMemberprsp:CivilianAndHealthCareSegmentMember2019-04-012019-12-310001724670prsp:FederalCustomersMember2019-04-012019-12-310001724670prsp:DefenseAndIntelligenceSegmentMemberprsp:NonFederalCustomersMember2020-04-012021-01-010001724670prsp:CivilianAndHealthCareSegmentMemberprsp:NonFederalCustomersMember2020-04-012021-01-010001724670prsp:NonFederalCustomersMember2020-04-012021-01-010001724670prsp:DefenseAndIntelligenceSegmentMemberprsp:NonFederalCustomersMember2019-04-012019-12-310001724670prsp:CivilianAndHealthCareSegmentMemberprsp:NonFederalCustomersMember2019-04-012019-12-310001724670prsp:NonFederalCustomersMember2019-04-012019-12-31xbrli:pure00017246702021-01-022021-01-0100017246702022-01-022021-01-010001724670prsp:FinancialInstitutionMember2020-04-012021-01-010001724670prsp:FinancialInstitutionMember2019-04-012019-12-3100017246702019-04-012020-03-310001724670us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2021-01-010001724670us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2020-03-310001724670us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2021-01-010001724670us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2020-03-310001724670us-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-010001724670us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-010001724670us-gaap:OtherCurrentLiabilitiesMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-010001724670us-gaap:OtherCurrentLiabilitiesMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-03-310001724670us-gaap:OtherLiabilitiesMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-010001724670us-gaap:OtherLiabilitiesMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-03-310001724670us-gaap:DesignatedAsHedgingInstrumentMember2021-01-010001724670us-gaap:DesignatedAsHedgingInstrumentMember2020-03-310001724670us-gaap:LondonInterbankOfferedRateLIBORMemberprsp:RevolvingCreditFacilityDue2023Memberus-gaap:SecuredDebtMember2020-04-012021-01-010001724670prsp:RevolvingCreditFacilityDue2023Memberus-gaap:SecuredDebtMember2021-01-010001724670prsp:RevolvingCreditFacilityDue2023Memberus-gaap:SecuredDebtMember2020-03-310001724670us-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:SecuredDebtMemberprsp:TermLoanADue2021Member2020-04-012021-01-010001724670us-gaap:SecuredDebtMemberprsp:TermLoanADue2021Member2021-01-010001724670us-gaap:SecuredDebtMemberprsp:TermLoanADue2021Member2020-03-310001724670prsp:TermLoanADue2023Memberus-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:SecuredDebtMember2020-04-012021-01-010001724670prsp:TermLoanADue2023Memberus-gaap:SecuredDebtMember2021-01-010001724670prsp:TermLoanADue2023Memberus-gaap:SecuredDebtMember2020-03-310001724670prsp:TermLoanBDue2025Memberus-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:SecuredDebtMember2020-04-012021-01-010001724670prsp:TermLoanBDue2025Memberus-gaap:SecuredDebtMember2021-01-010001724670prsp:TermLoanBDue2025Memberus-gaap:SecuredDebtMember2020-03-310001724670prsp:SeniorSecuredCreditFacilitiesMemberus-gaap:SecuredDebtMember2021-01-010001724670prsp:SeniorSecuredCreditFacilitiesMemberus-gaap:SecuredDebtMember2020-03-310001724670us-gaap:SecuredDebtMember2021-01-010001724670us-gaap:SecuredDebtMember2020-03-310001724670us-gaap:UnsecuredDebtMember2021-01-010001724670us-gaap:UnsecuredDebtMember2020-03-310001724670prsp:TermLoanAandBFacilitiesMemberus-gaap:SecuredDebtMember2021-01-010001724670prsp:TermLoanAandBFacilitiesMemberus-gaap:SecuredDebtMember2020-03-310001724670srt:MinimumMember2020-04-012021-01-010001724670srt:MaximumMember2020-04-012021-01-010001724670us-gaap:SubsequentEventMember2021-02-032021-02-030001724670us-gaap:CommonStockMember2020-04-012021-01-010001724670us-gaap:RestrictedStockUnitsRSUMember2020-04-012021-01-010001724670us-gaap:PerformanceSharesMember2020-04-012021-01-010001724670us-gaap:EmployeeStockMember2020-08-050001724670srt:MaximumMember2020-08-052020-08-050001724670srt:MinimumMember2020-08-052020-08-0500017246702020-10-012020-12-310001724670us-gaap:EmployeeStockMember2020-12-31prsp:segment0001724670us-gaap:OperatingSegmentsMember2020-10-032021-01-010001724670us-gaap:OperatingSegmentsMember2019-10-012019-12-310001724670us-gaap:OperatingSegmentsMember2020-04-012021-01-010001724670us-gaap:OperatingSegmentsMember2019-04-012019-12-310001724670us-gaap:CorporateNonSegmentMember2020-10-032021-01-010001724670us-gaap:CorporateNonSegmentMember2019-10-012019-12-310001724670us-gaap:CorporateNonSegmentMember2020-04-012021-01-010001724670us-gaap:CorporateNonSegmentMember2019-04-012019-12-310001724670us-gaap:PendingLitigationMemberprsp:Forsythetal.v.HPIncandHewlettPackardEnterpriceMember2016-08-182016-08-18prsp:plaintiff0001724670us-gaap:SettledLitigationMemberprsp:Forsythetal.v.HPIncandHewlettPackardEnterpriceMember2018-10-012018-10-310001724670us-gaap:PendingLitigationMemberprsp:Forsythetal.v.HPIncandHewlettPackardEnterpriceMember2019-06-262019-06-270001724670us-gaap:SettledLitigationMemberprsp:Forsythetal.v.HPIncandHewlettPackardEnterpriceMember2019-12-232019-12-230001724670us-gaap:SuretyBondMemberus-gaap:GuaranteeObligationsMember2021-01-010001724670us-gaap:SubsequentEventMemberprsp:MergerAgreementMember2021-01-27

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended January 1, 2021


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____________ to ____________

Commission File Number: 001-38033


PERSPECTA INC.
(Exact Name of Registrant as Specified in Its Charter)

Nevada		82-3141520
(State or Other Jurisdiction of Incorporation or Organization)		(I.R.S. Employer Identification No.)
14295 Park Meadow Drive, Chantilly, Virginia		20151
(Address of Principal Executive Offices)		(Zip Code)
Registrant’s telephone number, including area code: (571) 313-6000
Securities registered pursuant to Section 12(b) of the Act:
Title of each class	Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.01 par value per share	PRSP		New York Stock Exchange

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer ☒			Accelerated filer ☐
Non-accelerated filer ☐			Smaller reporting company ☐
			Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No

161,070,907 shares of common stock, par value $0.01 per share, were outstanding as of January 29, 2021.

TABLE OF CONTENTS


Item		Page
	PART I – FINANCIAL INFORMATION

1.	Financial Statements (unaudited)	1
2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	21
3.	Quantitative and Qualitative Disclosures About Market Risk	31
4.	Controls and Procedures	31

	PART II – OTHER INFORMATION

1.	Legal Proceedings	33
1A.	Risk Factors	33
2.	Unregistered Sales of Equity Securities and Use of Proceeds	34
3.	Defaults Upon Senior Securities	35
4.	Mine Safety Disclosures	35
5.	Other Information	35
6.	Exhibits	35

	Signature	36

Table of Contents

PART I – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

Index to Condensed Consolidated Financial Statements (unaudited)


			Page
Condensed Consolidated Statements of Operations for the Fiscal Quarter and Three Fiscal Quarters Ended January 1, 2021 and December 31, 2019 (unaudited)			2
Condensed Consolidated Statements of Comprehensive Income for the Fiscal Quarter and T hree Fiscal Quarters Ended January 1 , 202 1 and December 3 1 , 20 19 (unaudited)			3
Condensed Consolidated Balance Sheets as of January 1, 202 1 and March 31, 2020 (unaudited)			4
Condensed Consolidated Statements of Changes in Shareholders’ Equity for the Fiscal Quarter and T hree Fiscal Quarters Ended January 1, 2021 and Dec ember 3 1 , 20 19 (unaudited)			5
Condensed Consolidated Statements of Cash Flows for the T hree Fiscal Quarters Ended January 1, 2021 and Dec ember 3 1 , 20 1 9 (unaudited)			6
Notes to Condensed Consolidated Financial Statements (unaudited)
Note 1 – Overview and Basis of Presentation			7
Note 2 – Recent Accounting Pronouncements			8

Note 3 – Acquisitions			8
Note 4 – Revenue			9
Note 5 – Earnings Per Share			11
Note 6 – Sale of Receivables			11
Note 7 – Fair Value			11
Note 8 – Derivative Instruments			12


Note 9 – Debt			12
Note 10 – Leases			13
Note 11 – Pension and Other Benefit Plans			14
Note 12 – Income Taxes			15

Note 13 – Shareholders’ Equity			15

Note 14 – Segment Information			16
Note 15 – Commitments and Contingencies			17
Note 16 – Subsequent Events			19

Table of Contents

PERSPECTA INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)


	Fiscal Quarter Ended				Three Fiscal Quarters Ended
(in millions, except per share amounts)	January 1, 2021		December 31, 2019		January 1, 2021		December 31, 2019
Revenue	$	1,134	$	1,126	$	3,384	$	3,405

Costs of services	906		863		2,717		2,607
Selling, general and administrative	57		77		184		230
Depreciation and amortization	93		92		285		283
Restructuring costs	2		—		33		4
Separation, transaction and integration-related costs	7		20		34		59
Interest expense, net	28		34		87		105
Other (income) expense, net	(4)		(35)		(23)		(37)
Total costs and expenses	1,089		1,051		3,317		3,251

Income before taxes	45		75		67		154
Income tax expense	14		22		23		41
Net income	$	31	$	53	$	44	$	113

Earnings per common share:
Basic	$	0.19	$	0.33	$	0.27	$	0.70
Diluted	$	0.19	$	0.33	$	0.27	$	0.69

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Table of Contents

PERSPECTA INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(unaudited)


		Fiscal Quarter Ended						Three Fiscal Quarters Ended
(in millions)			January 1, 2021			December 31, 2019			January 1, 2021			December 31, 2019
Net income			$	31		$	53		$	44		$	113
Other comprehensive income, net of taxes:

Change in net unrealized losses on cash flow hedges:
Net unrealized gains (losses) arising during the period, net of tax effect of $0, $2, $2 and $6, respectively		(1)			4			(8)			(19)
Amounts reclassified to earnings, net of tax effect of $1, $1, $6 and $2, respectively			10			3			24			5
Other comprehensive income (loss), net of taxes	9		7			16			(14)
Comprehensive income			$	40		$	60		$	60		$	99

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Table of Contents

PERSPECTA INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(unaudited)


(in millions, except per share and share amounts)	January 1, 2021		March 31, 2020
ASSETS
Current assets:
Cash and cash equivalents	$	224	$	147
Receivables, net of allowance for doubtful accounts of $1 and $1	531		513

Other receivables	11		45
Prepaid expenses	63		81


Other current assets	69		101
Total current assets	898		887
Property and equipment, net of accumulated depreciation of $280 and $193	262		307
Goodwill	2,702		2,671
Intangible assets, net of accumulated amortization of $691 and $515	1,026		1,193

Other assets	314		347
Total assets	$	5,202	$	5,405
LIABILITIES and SHAREHOLDERS’ EQUITY
Current liabilities:
Current maturities of long-term debt	$	90	$	89
Current finance lease obligations	96		111
Current operating lease obligations	33		39
Accounts payable	191		218
Accrued payroll and related costs	203		142
Accrued expenses	363		385



Other current liabilities	96		73
Total current liabilities	1,072		1,057
Long-term debt, net of current maturities	2,123		2,283
Non-current finance lease obligations	95		136
Non-current operating lease obligations	126		129


Deferred tax liabilities	71		114
Other long-term liabilities	307		329
Total liabilities	3,794		4,048
Commitments and contingencies
Shareholders’ equity:

Common stock, par value $0.01 per share; 750,000,000 shares authorized; 166,765,525 and 166,219,561 shares issued; 161,038,915 and 160,583,052 shares outstanding	2		2
Additional paid-in capital	2,259		2,266
Accumulated deficit	(669)		(713)
Accumulated other comprehensive loss	(53)		(69)
Treasury shares at cost, 5,726,610 shares and 5,636,509 shares	(131)		(129)
Total shareholders’ equity	1,408		1,357
Total liabilities and shareholders’ equity	$	5,202	$	5,405

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Table of Contents

PERSPECTA INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

(unaudited)


(in millions, except shares in thousands and per share amounts in ones)	Common Stock			Additional Paid-in Capital		Accumulated Deficit		Accumulated Other Comprehensive Loss		Treasury Shares		Total Shareholders’ Equity
	Shares	Amount
Balance at March 31, 2020	166,220	$	2	$	2,266	$	(713)	$	(69)	$	(129)	$	1,357
Net loss	—	—		—		(3)		—		—		(3)

Share-based compensation	—	—		7		—		—		—		7

Stock option exercises and other common stock transactions	250	—		—		—		—		(2)		(2)
Dividends declared ($0.07 per common share)	—	—		(11)		—		—		—		(11)
Balance at July 3, 2020	166,470	2		2,262		(716)		(69)		(131)		1,348
Net income	—	—		—		16		—		—		16
Other comprehensive income, net of tax	—	—		—		—		7		—		7
Share-based compensation	—	—		10		—		—		—		10

Stock option exercises and other common stock transactions	63	—		—		—		—		—		—
Dividends declared ($0.07 per common share)	—	—		(12)		—		—		—		(12)
Balance at October 2, 2020	166,533	2		2,260		(700)		(62)		(131)		1,369
Net income	—	—		—		31		—		—		31
Other comprehensive income, net of tax	—	—		—		—		9		—		9
Share-based compensation	—	—		10		—		—		—		10

Stock option exercises and other common stock transactions	233	—		—		—		—		—		—
Dividends declared ($0.07 per common share)	—	—		(11)		—		—		—		(11)
Balance at January 1, 2021	166,766	$	2	$	2,259	$	(669)	$	(53)	$	(131)	$	1,408


(in millions, except shares in thousands and per share amounts in ones)	Common Stock			Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Loss		Treasury Shares		Total Shareholders’ Equity
	Shares	Amount
Balance at March 31, 2019	165,845	$	2	$	2,242	$	2	$	(23)	$	(61)	$	2,162
Net income	—	—		—		31		—		—		31
Other comprehensive loss, net of tax	—	—		—		—		(18)		—		(18)
Share-based compensation expense	—	—		5		—		—		—		5
Repurchases of common stock	—	—		—		—		—		(15)		(15)
Stock option exercises and other common stock transactions	42	—		—		—		—		—		—
Dividends declared ($0.06 per common share)	—	—		—		(10)		—		—		(10)
Balance at June 30, 2019	165,887	2		2,247		23		(41)		(76)		2,155
Net income	—	—		—		29		—		—		29
Other comprehensive loss, net of tax	—	—		—		—		(3)		—		(3)
Share-based compensation expense	—	—		10		—		—		—		10
Repurchases of common stock	—	—		—		—		—		(17)		(17)
Stock option exercises and other common stock transactions	100	—		—		—		—		(1)		(1)
Dividends declared ($0.06 per common share)	—	—		—		(10)		—		—		(10)
Balance at September 30, 2019	165,987	2		2,257		42		(44)		(94)		2,163
Net income	—	—		—		53		—		—		53
Other comprehensive income, net of tax	—	—		—		—		7		—		7
Share-based compensation expense	—	—		6		—		—		—		6
Repurchases of common stock	—	—		—		—		—		(13)		(13)
Stock option exercises and other common stock transactions	231	—		1		—		—		(1)		—
Dividends declared ($0.06 per common share)	—	—		—		(10)		—		—		(10)
Balance at December 31, 2019	166,218	$	2	$	2,264	$	85	$	(37)	$	(108)	$	2,206

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Table of Contents

PERSPECTA INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)


	Three Fiscal Quarters Ended
(in millions)	January 1, 2021		December 31, 2019
Cash flows from operating activities:
Net income	$	44	$	113
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	285		283

Share-based compensation	27		21

Deferred income taxes	(48)		4
Loss (gain) on sale or disposal of assets, net	12		(23)

Other non-cash charges, net	12		3
Changes in assets and liabilities, net of effects of acquisitions:
Receivables, net	51		49
Prepaid expenses and other current assets	16		38
Accounts payable, accrued expenses and other current liabilities	28		(20)

Deferred revenue and advanced contract payments	1		(24)
Income taxes payable and liability	(3)		(6)
Other assets and liabilities, net	(12)		2
Net cash provided by operating activities	413		440
Cash flows from investing activities:
Payments for acquisitions, net of cash acquired	(53)		(265)

Proceeds from sale of assets	10		77
Purchases of property, equipment and software	(32)		(11)
Payments for outsourcing contract costs	—		(4)


Net cash used in investing activities	(75)		(203)
Cash flows from financing activities:
Principal payments on long-term debt	(124)		(69)

Payments of debt issuance costs	—		(3)
Proceeds from revolving credit facility	—		175
Payments on revolving credit facility	(50)		(125)
Payments on finance lease obligations	(85)		(110)
Repurchases of common stock	—		(46)
Repurchases of common stock to satisfy tax withholding obligations	(3)		(2)

Dividends paid	(32)		(28)

Proceeds from employee stock purchase plan	1		—
Net cash used in financing activities	(293)		(208)
Net change in cash and cash equivalents, including restricted	45		29
Cash and cash equivalents, including restricted, at beginning of period	221		99
Cash and cash equivalents, including restricted, at end of period	266		128
Less restricted cash and cash equivalents included in other current assets	42		59
Cash and cash equivalents at end of period	$	224	$	69
Supplemental cash flow disclosures:
Interest paid, net	$	81	$	97
Income taxes paid (refunded), net	31		11
Supplemental schedule of non-cash investing and financing activities:
Leased assets acquired through finance lease obligations	$	30	$	69
Leased assets acquired through operating lease obligations	36		47

Dividends declared but not yet paid	11		10

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Table of Contents

PERSPECTA INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

Note 1 – Overview and Basis of Presentation

Background

Perspecta Inc. (“Perspecta,” “the Company,” “we,” “us,” and “our”) is a leading provider of end-to-end enterprise information technology (“IT”), mission, and operations-related services across the United States (“U.S.”) federal government to the Department of Defense (“DoD”), the intelligence community, and homeland security, civilian and health care agencies, as well as to certain state and local government agencies through two reportable segments: (1) Defense and Intelligence, which provides services to the DoD, intelligence community, branches of the U.S. Armed Forces, and other DoD agencies, and (2) Civilian and Health Care, which provides services to the Departments of Homeland Security, Justice, and Health and Human Services, as well as other federal civilian and state and local government agencies.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements and should be read in conjunction with the information contained in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2020.

Effective April 1, 2020, Perspecta’s fiscal year was modified to end on the Friday nearest March 31 of each year, with each fiscal year generally comprised of four thirteen-week fiscal quarters ending on the Friday nearest the end of calendar months June, September, December and March. As a result, fiscal year 2021 will contain 52 weeks and three days beginning April 1, 2020 and ending April 2, 2021, and this Quarterly Report on Form 10-Q covers the period beginning October 3, 2020 and ending January 1, 2021.

Principles of Consolidation and Combination

The accompanying interim unaudited condensed consolidated financial statements reflect the financial position and results of operations of the Company and its consolidated subsidiaries.

In the opinion of management of the Company, the accompanying interim unaudited condensed consolidated financial statements contain all adjustments, including normal recurring adjustments, necessary to present fairly our results of operations and cash flows.

Use of Estimates

The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes.

Amounts subject to significant judgment and/or estimates include, but are not limited to, determining the fair value of assets acquired and liabilities assumed, the evaluation of impairment of goodwill and other long-lived intangible assets, costs to complete fixed-price contracts, fair value, certain deferred costs, valuation allowances on deferred tax assets, loss accruals for litigation, and inputs used for computing shared-based compensation and pension related liabilities. These estimates are based on management’s best knowledge of historical experience, current events, and various other assumptions that management considers reasonable under the circumstances.

Reclassifications

Certain prior period balances in the accompanying financial statements have been reclassified to conform to the current

period presentation, including the separate reporting of non-current operating lease obligations in the accompanying condensed consolidated balance sheets. These reclassifications had no impact on total assets, total liabilities, total equity, income before taxes or net income.

Table of Contents

Note 2 – Recent Accounting Pronouncements

Recently Adopted Accounting Pronouncements

In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). The guidance, along with related amendments, changes the impairment model for most financial assets. The new model uses a forward-looking expected loss method, which requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. Perspecta adopted the standard on April 1, 2020. The adoption of ASU 2016-13 did not have a material impact on Perspecta’s financial statements given the Company’s historically high collection results due to a concentration of receivables with the U.S. government.

In August 2018, the FASB issued ASU 2018-15, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350- 40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (“ASU 2018-15”). ASU 2018-15 provides guidance for determining when a cloud computing arrangement includes a software license and makes changes to the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract. The Company adopted ASU 2018-15 on April 1, 2020 and will apply it to implementation costs incurred after the date of adoption. The adoption of ASU 2018-15 has not had a material impact thus far, and the future impact on Perspecta's financial statements and disclosures will depend on the volume of cloud-based solutions implemented.

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides companies with optional expedients and exceptions to ease the potential accounting burden associated with transitioning away from reference rates that are expected to be discontinued. The optional expedients may be applied to contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of the reference rate reform. The amendments in this update are effective for all entities as of March 12, 2020 and may be adopted using a prospective approach through December 31, 2022. In January 2021, the FASB issued ASU 2021-01, Reference Rate Reform (Topic 848): Scope, which clarifies that derivatives affected by discounting transition are explicitly eligible for certain optional expedients and exceptions in Topic 848. The guidance in Topic 848 is expected to have an impact on hedge designation as contract modifications and other changes occur while LIBOR is phased out, but is not expected to have a material impact on Perspecta’s financial statements. The Company has elected to apply the hedge accounting expedients related to probability and the assessments of effectiveness for future LIBOR-indexed cash flows to assume that the index upon which future hedged transactions will be based matches the index on the corresponding derivatives. Application of these expedients preserves the presentation of derivatives consistent with past presentation. The Company continues to evaluate the impact of the guidance and may apply other elections as applicable as additional changes in the market occur during the LIBOR transition period.

Recently Issued Accounting Pronouncements Not Yet Adopted

Other recently issued ASUs effective after January 1, 2021 are not expected to have a material impact on Perspecta’s financial statements.

Note 3 – Acquisitions

DHPC Technologies, Inc. Acquisition

On May 1, 2020, Perspecta completed the acquisition of DHPC Technologies, Inc. (“DHPC”), a U.S. developer of electronic warfare technologies with market-leading technical solutions and a solid, proven reputation with Army customers. The purchase consideration was approximately $53 million in cash. The Company recognized preliminary fair values of the assets acquired and liabilities assumed and allocated approximately $31 million to goodwill and $20 million to intangible assets, reported in the Defense and Intelligence segment. The intangible assets consist primarily of program assets of $18 million and backlog of $2 million. The estimated fair value attributed to intangible assets is being amortized on an accelerated basis over 20 years for program assets and approximately one year for backlog. The fair value attributed to the intangible assets acquired was based on preliminary estimates, assumptions, and other information compiled by management, including independent valuations that utilized established valuation techniques. All of the value attributed to goodwill and intangible assets is deductible for income tax purposes. The fair values of assets acquired and liabilities assumed are preliminary and based on a valuation using estimates and assumptions that are subject to change,

Table of Contents

which could result in changes to the purchase price allocation. The fair values of the assets acquired and liabilities assumed and the results of operations are not material to the operations of Perspecta. The final purchase price allocation is expected to be completed during fiscal year 2021.

The results of operations of DHPC have been included in the statements of operations beginning May 1, 2020. Pro forma results of operations for this acquisition have not been presented as it is not material to the consolidated results of operations. The acquisition was considered an asset purchase for tax purposes.

Knight Point Systems, LLC

On July 31, 2019, Perspecta acquired all of the equity interests of Knight Point Systems, LLC (“Knight Point”) for $264 million. Knight Point delivers end-to-end managed services and solutions focused on modernizing IT systems, protecting critical networks and driving digital transformation to improve customer transparency and operational efficiency. Knight Point leverages a portfolio of intellectual property to solve complex customer challenges in cloud, cybersecurity and agile development and operations environments.

The Company completed the purchase accounting for the Knight Point acquisition in the first quarter of fiscal year 2021, and made no material changes to the fair values of assets acquired and liabilities assumed reported in our Annual Report on Form 10-K for the fiscal year ended March 31, 2020.

The results of operations of Knight Point have been included in the statements of operations beginning August 1, 2019. Pro forma results of operations for this acquisition have not been presented as it is not material to the consolidated results of operations. The acquisition was considered an asset purchase for tax purposes. All of the value attributed to goodwill and intangible assets is deductible for income tax purposes.

Note 4 – Revenue

Disaggregated Revenue

Revenue by contract type was as follows:


	Fiscal Quarter Ended January 1, 2021						Fiscal Quarter Ended December 31, 2019
(in millions)	Defense and Intelligence		Civilian and Health Care		Total		Defense and Intelligence		Civilian and Health Care		Total
Cost-reimbursable	$	320	$	48	$	368	$	283	$	27	$	310
Fixed-price	407		193		600		435		173		608
Time-and-materials	68		98		166		95		113		208
Total	$	795	$	339	$	1,134	$	813	$	313	$	1,126

	Three Fiscal Quarters Ended January 1, 2021						Three Fiscal Quarters Ended December 31, 2019
(in millions)	Defense and Intelligence		Civilian and Health Care		Total		Defense and Intelligence		Civilian and Health Care		Total
Cost-reimbursable	$	977	$	156	$	1,133	$	818	$	78	$	896
Fixed-price	1,172		606		1,778		1,218		638		1,856
Time-and-materials	218		255		473		306		347		653
Total	$	2,367	$	1,017	$	3,384	$	2,342	$	1,063	$	3,405

Table of Contents

Revenue as a prime or subcontractor was as follows:


	Fiscal Quarter Ended January 1, 2021						Fiscal Quarter Ended December 31, 2019
(in millions)	Defense and Intelligence		Civilian and Health Care		Total		Defense and Intelligence		Civilian and Health Care		Total
Prime contractor	$	735	$	318	$	1,053	$	762	$	290	$	1,052
Subcontractor	60		21		81		51		23		74
Total	$	795	$	339	$	1,134	$	813	$	313	$	1,126

	Three Fiscal Quarters Ended January 1, 2021						Three Fiscal Quarters Ended December 31, 2019
(in millions)	Defense and Intelligence		Civilian and Health Care		Total		Defense and Intelligence		Civilian and Health Care		Total
Prime contractor	$	2,191	$	948	$	3,139	$	2,203	$	985	$	3,188
Subcontractor	176		69		245		139		78		217
Total	$	2,367	$	1,017	$	3,384	$	2,342	$	1,063	$	3,405

Revenue by customer type was as follows:


	Fiscal Quarter Ended January 1, 2021						Fiscal Quarter Ended December 31, 2019
(in millions)	Defense and Intelligence		Civilian and Health Care		Total		Defense and Intelligence		Civilian and Health Care		Total
U.S. federal government, including independent agencies	$	792	$	284	$	1,076	$	808	$	248	$	1,056
Non-federal (state, local and other)	3		55		58		5		65		70
Total	$	795	$	339	$	1,134	$	813	$	313	$	1,126

	Three Fiscal Quarters Ended January 1, 2021						Three Fiscal Quarters Ended December 31, 2019
(in millions)	Defense and Intelligence		Civilian and Health Care		Total		Defense and Intelligence		Civilian and Health Care		Total
U.S. federal government, including independent agencies	$	2,357	$	847	$	3,204	$	2,329	$	862	$	3,191
Non-federal (state, local and other)	10		170		180		13		201		214
Total	$	2,367	$	1,017	$	3,384	$	2,342	$	1,063	$	3,405

Performance Obligations

As of January 1, 2021, approximately $3.49 billion of revenue is expected to be recognized from remaining unsatisfied performance obligations on executed contracts. The Company expects to recognize approximately 78% of these remaining performance obligations as revenue within 12 months and approximately 91% within 24 months, with the remainder recognized thereafter.

Contract Balances

Contract assets and contract liabilities were as follows:


(in millions)	Balance Sheets Line Item	January 1, 2021		March 31, 2020
Contract assets:
Unbilled receivables	Receivables, net of allowance for doubtful accounts	$	435	$	341
Contract liabilities:
Current portion of deferred revenue and advance contract payments	Other current liabilities	$	31	$	25
Non-current portion of deferred revenue and advance contract payments	Other long-term liabilities	$	—	$	2

Table of Contents

Contract assets increased $94 million during the three fiscal quarters ended January 1, 2021, primarily due to new programs and growth in existing programs. There were no significant impairment losses related to the Company’s contract assets during the three fiscal quarters ended January 1, 2021.

Contract liabilities increased $4 million during the three fiscal quarters ended January 1, 2021, primarily due to payments received in excess of revenue recognized. During the fiscal quarter and three fiscal quarters ended January 1, 2021, the Company recognized $1 million and $17 million, respectively, of the deferred revenue and advance contract payments at March 31, 2020 as revenue. During the fiscal quarter and three fiscal quarters ended December 31, 2019, the Company recognized $2 million and $31 million, respectively, of the deferred revenue and advance contract payments at March 31, 2019 as revenue.

Note 5 – Earnings Per Share

Basic earnings per common share (“EPS”) is computed using the weighted average number of shares of common stock outstanding. Diluted EPS reflects the incremental shares issuable upon the assumed exercise of stock options and vesting of other equity awards. There were no significant anti-dilutive equity awards excluded from the calculation of EPS for the fiscal quarters and three fiscal quarters ended January 1, 2021 or December 31, 2019.

The following table reflects the calculation of basic and diluted EPS:


	Fiscal Quarter Ended				Three Fiscal Quarters Ended
(in millions, except per share amounts)	January 1, 2021		December 31, 2019		January 1, 2021		December 31, 2019
Net income	$	31	$	53	$	44	$	113
Common share information:
Basic weighted average common shares outstanding	160.96		161.69		160.80		162.24
Dilutive effect of equity awards	1.17		0.78		1.11		0.64
Diluted weighted average common shares outstanding	162.13		162.47		161.91		162.88
Earnings per common share:
Basic	$	0.19	$	0.33	$	0.27	$	0.70
Diluted	$	0.19	$	0.33	$	0.27	$	0.69

Note 6 – Sale of Receivables

During the fiscal quarters ended January 1, 2021 and December 31, 2019, we sold $1.01 billion and $984 million, respectively, of billed and unbilled receivables under our accounts receivable sales facility. During the three fiscal quarters ended January 1, 2021 and December 31, 2019, we sold $2.82 billion and $2.39 billion, respectively, of billed and unbilled receivables under our accounts receivable sales facility. Collections on sold receivables were $1.03 billion and $894 million during the fiscal quarters ended January 1, 2021 and December 31, 2019, respectively. During the three fiscal quarters ended January 1, 2021 and December 31, 2019, collections on sold receivables were $2.80 billion and $2.30 billion, respectively.

The amounts outstanding at January 1, 2021 and March 31, 2020 were $278 million and $255 million, respectively. As of January 1, 2021 and March 31, 2020, there were $22 million and $63 million, respectively, of cash collected by the Company but not remitted to the financial institutions, which represents restricted cash recorded by the Company within the other current assets caption on the accompanying balance sheets.

Note 7 – Fair Value

The Company estimates the fair value of its long-term debt primarily using an expected present value technique, which is based on observable market inputs, using interest rates currently available to the Company for instruments with similar terms and remaining maturities. The estimated fair value of the Company’s long-term debt, excluding finance leases and unamortized debt issuance costs, was $2.20 billion and $2.18 billion as of January 1, 2021 and March 31, 2020, respectively, as compared with the gross carrying value of $2.23 billion and $2.39 billion, respectively. If measured at fair value, long-term debt, excluding finance lease obligations, would be classified in Level 2 of the fair value hierarchy.

Table of Contents

Non-financial assets such as goodwill, tangible assets, intangible assets and other contract related long-lived assets are reduced to fair value in the period an impairment charge is recognized. The fair value measurements, in such instances, would be classified in Level 3. There were no significant impairments recorded during the fiscal periods ended January 1, 2021 or December 31, 2019.

Note 8 – Derivative Instruments

In the normal course of business, the Company is exposed to interest rate fluctuations. As part of its risk management strategy, the Company uses derivative instruments, primarily interest rate swaps, to hedge certain interest rate exposures. The Company’s objective is to add stability to interest expense and to manage its exposure to movements in market interest rates. The Company does not use derivative instruments for trading or any speculative purpose. The Company’s derivative instruments are designated as cash flow hedges, and therefore, all changes in the hedging instruments’ fair value are recorded in accumulated other comprehensive loss (“AOCL”) and subsequently reclassified into earnings in the period during which the hedged transactions are recognized in earnings.

As of January 1, 2021, the Company had interest rate swap agreements with a total notional amount of $2.50 billion. As of January 1, 2021, we expect amounts of approximately $37 million pertaining to cash flow hedges to be reclassified from AOCL into earnings over the next 12 months.

All derivatives are recorded at fair value on a recurring basis. The Company’s accounting treatment for these derivative instruments is based on its hedge designation. The fair value of interest rate swaps is estimated based on valuation models that use interest rate yield curves as Level 2 inputs. The gross fair value of our derivative liabilities in interest rate swaps designated for hedge accounting were as follow:


(in millions)	Balance Sheets Line Item	January 1, 2021		March 31, 2020
Derivative liabilities:
Interest rate swaps	Other current liabilities	$	36	$	37
Interest rate swaps	Other liabilities	32		50
Total derivative liabilities		$	68	$	87

Note 9 – Debt

The following is a summary of the Company’s outstanding debt:


(in millions)	Interest Rates	Maturities	January 1, 2021		March 31, 2020
Revolving Credit Facility	LIBOR + 1.50%	August 2024	$	—	$	50
Term Loan A Facilities (Tranche 1)	LIBOR + 1.375%	August 2022	200		200
Term Loan A Facilities (Tranche 2)	LIBOR + 1.50%	August 2024	1,490		1,552
Term Loan B Facility	LIBOR + 2.25%	May 2025	437		491
Subtotal senior secured credit facilities			2,127		2,293
Other secured borrowings	Various	Various	13		12
Total secured debt			2,140		2,305
Other unsecured borrowings	Various	Various	19		18
Senior unsecured EDS Notes	7.45%	October 2029	66		66
Total debt			2,225		2,389
Less: current maturities of long-term debt, net(1)			(90)		(89)
Less: unamortized debt issuance costs and premiums, net(2)			(12)		(17)
Total long-term debt, net of current maturities			$	2,123	$	2,283

(1) Current maturities of long-term debt are presented net of $6 million of debt issuance costs as of January 1, 2021 and March 31, 2020, associated with the Term Loan A Facilities and Term Loan B Facility.

(2) Includes $10 million and $11 million of unamortized premiums as of January 1, 2021 and March 31, 2020, respectively, on the assumed Electronic Data Systems Corporation (“EDS”) Notes.

Table of Contents

Expected maturities of long-term debt are as follows:


Fiscal Year	(in millions)
Remainder of fiscal year 2021	$	25
2022	93
2023	290
2024	88
2025	1,225
Thereafter	504
Total	$	2,225

Note 10 – Leases

The components of lease expense were as follows:


		Fiscal Quarter Ended				Three Fiscal Quarters Ended
(in millions)	Statement of Operations Line Item(s)	January 1, 2021		December 31, 2019		January 1, 2021		December 31, 2019
Finance lease expense
Amortization of leased assets	Depreciation and amortization	$	25	$	29	$	78	$	94
Interest on lease obligations	Interest expense, net	3		5		10		15
Total finance lease expense		28		34		88		109
Operating lease expense	Cost of services and selling, general and administrative	11		12		33		42
Variable lease expense	Cost of services and selling, general and administrative	3		3		10		7
Sublease income	Cost of services and selling, general and administrative	—		(1)		(2)		(3)
Total lease expense, net		$	42	$	48	$	129	$	155

The weighted average remaining lease terms and discount rates were as follows:


	January 1, 2021		December 31, 2019
Weighted average remaining lease term (in years):

Finance leases	2.4		2.7
Operating leases	5.4		4.6
Weighted average discount rate:

Finance leases	5.89	%	6.34	%
Operating leases	4.36	%	4.57	%

Table of Contents

As of January 1, 2021, future minimum lease payments required to be made under leases were as follows:


Fiscal Year (in millions)	Operating Leases		Finance Leases
Remainder of fiscal year 2021	$	7	$	34
2022	41		90
2023	37		50
2024	27		21
2025	22		8
Thereafter	45		1
Total minimum lease payments	179		204
Less: Amount representing interest	(20)		(13)
Present value of net minimum lease payments	$	159	$	191

As of January 1, 2021, the Company had aggregate rent obligations of $13 million for operating leases and $1 million for finance leases, for leases that have not commenced, with terms ranging from three to eight years.

In response to the coronavirus disease 2019 (“COVID-19”) pandemic, we implemented telework initiatives in the fourth quarter of fiscal year 2020. Due to the success of those initiatives and a decision to utilize increased telework arrangements, we evaluated our real estate footprint and implemented a facility rationalization restructuring plan during the fiscal quarter ended July 3, 2020, identifying 20 facilities that would no longer be utilized. During the fiscal quarter ended October 2, 2020, we identified an additional four facilities that would no longer be utilized, bringing the total to 24 facilities. Restructuring charges of $2 million and $33 million were recognized during the fiscal quarter and three fiscal quarters ended January 1, 2021, respectively, including $21 million of right-of-use assets that were abandoned. At January 1, 2021, $19 million of this restructuring liability remained unpaid, primarily included in operating lease obligations.

Note 11 – Pension and Other Benefit Plans

The Company offers a defined benefit pension plan, a retiree medical plan, life insurance benefits, deferred compensation plans and defined contribution plans. The Company’s defined benefit pension and retiree medical plans are not admitting new participants; therefore, changes to pension and other postretirement benefit liabilities are primarily due to market fluctuations of investments, actuarial assumptions for the measurement of liabilities and changes in interest rates.

The Company contributed $0 million and $7 million to the defined benefit pension and other postretirement benefit plans during the fiscal quarter and three fiscal quarters ended January 1, 2021, respectively. The Company did not contribute to the defined benefit pension and other postretirement benefit plans during the fiscal quarter and three fiscal quarters ended December 31, 2019. The Company does not expect to contribute during the remainder of fiscal year 2021.

The components of net periodic pension benefit were:


	Fiscal Quarter Ended				Three Fiscal Quarters Ended
(in millions)	January 1, 2021		December 31, 2019		January 1, 2021		December 31, 2019
Service cost	$	—	$	1	$	—	$	2
Interest cost	4		4		13		13
Expected return on assets	(6)		(7)		(18)		(22)
Net periodic pension benefit	$	(2)	$	(2)	$	(5)	$	(7)

Net periodic benefit cost for the Company’s retiree medical plan was not significant for the fiscal quarters and three fiscal quarters ended January 1, 2021 or December 31, 2019.

Table of Contents

Note 12 – Income Taxes

The Company’s effective tax rate (“ETR”) was approximately 31% and 34% for the fiscal quarter and three fiscal quarters ended January 1, 2021, respectively, as compared to 29% and 27% for the fiscal quarter and three fiscal quarters ended December 31, 2019, respectively. For the fiscal quarter and three fiscal quarters ended January 1, 2021, the primary drivers of our ETR were state income taxes, adjustments to indemnified taxes receivable and limitations on executive compensation deductions. For the fiscal quarter and three fiscal quarters ended December 31, 2019, the primary drivers of our ETR were state income taxes, including a valuation allowance against a state interest deduction limit carryforward.

The Company is bound by a Tax Matters Agreement (“TMA”) with DXC Technology Company (“DXC”), executed as of May 31, 2018, the date when Perspecta became an independent company through the consummation of the spin-off of the DXC U.S. Public Sector (“USPS”) business (the “Spin-Off”), and mergers with Vencore Holding Corp. (“Vencore HC”) and KGS Holding Corp. (“KGS HC”) (the “Mergers”). The TMA states each company’s rights and responsibilities with respect to payment of taxes, tax return filings and control of tax examinations. For certain of our tax years ending prior to June 1, 2018, we may have joint and several liability with DXC, Hewlett Packard Enterprise Company (“HPE”) and/or HP Inc. to the Internal Revenue Service (“IRS”) for the consolidated U.S. federal income taxes of DXC or predecessor consolidated groups relating to the taxable periods in which we were part of that group. The TMA specifies the portion, if any, of this tax liability for which we would bear responsibility, and DXC agrees to indemnify us against any amounts for which the Company is not responsible. Except for Vencore HC and KGS HC, the Company is generally only responsible for tax assessments, penalties and interest allocable to periods (or portions of periods) beginning after June 1, 2018. The TMA also provides special rules for allocating tax liabilities in the event the Spin-Off is determined not to be tax-free. Though valid as between the parties, the TMA is not binding on the IRS.

The Company had income tax refunds receivable from the IRS and various state tax authorities of approximately $47 million at January 1, 2021, for which it must remit to DXC under the TMA and has recorded a corresponding payable. The receivable is included in other receivables and other assets and the payable is included in accrued expenses, other current liabilities and other long-term liabilities on our balance sheet.

The Company engages in continuous discussion and negotiation with taxing authorities regarding tax matters in various jurisdictions. The Company is subject to income tax in the U.S. at the federal and state level and is subject to routine corporate income tax audits in these jurisdictions. The Company’s entities included in the Spin-Off are currently under examination or in appeals in several tax jurisdictions. Tax years remaining open for IRS and/or state taxing authority examination or review under applicable statutes of limitations are calendar years 2007 and 2008, fiscal year 2010, and fiscal years 2016 and forward. The IRS is not currently examining Perspecta Inc., Vencore HC or KGS HC for any open years, but entities related to these businesses remain open to examination federally and in various state and local jurisdictions.

Note 13 – Shareholders’ Equity

Cash Dividends

During the fiscal quarters ended January 1, 2021 and December 31, 2019, the Board of Directors declared cash dividends to our shareholders of approximately $11 million ($0.07 per common share) and $10 million ($0.06 per common share), respectively. During the three fiscal quarters ended January 1, 2021 and December 31, 2019, the Board of Directors declared cash dividends to our shareholders of approximately $34 million ($0.21 per common share) and $30 million ($0.18 per common share), respectively. The cash dividends were paid in the fiscal quarter following their declaration.

On February 3, 2021, the Board of Directors declared a dividend of $0.07 per common share payable on April 15, 2021 to common shareholders of record at the close of business on March 3, 2021.

Share Repurchase Program

During the three fiscal quarters ended January 1, 2021, the Company did not repurchase any shares of its common stock. The total remaining authorization for future common stock repurchases under the share repurchase program was $275 million as of January 1, 2021.

Table of Contents

Share-based Compensation

The Company recognized $10 million and $6 million in share-based compensation expense during the fiscal quarters ended January 1, 2021 and December 31, 2019, respectively. The Company recognized $27 million and $21 million in share-based compensation for the three fiscal quarters ended January 1, 2021 and December 31, 2019, respectively. During the three fiscal quarters ended January 1, 2021, the Company granted approximately 1.2 million time-based restricted stock units (“RSUs”) and approximately 918 thousand performance-based restricted stock units (“PSUs”). The RSUs and PSUs are valued using the closing price on the trading day of the grant. The weighted average grant date fair value of the RSUs and PSUs granted during the three fiscal quarters ended January 1, 2021 was $23.76 and $23.98, respectively.

Employee Stock Purchase Plan

On August 5, 2020, the Company’s shareholders approved the Perspecta Inc. Employee Stock Purchase Plan (the “ESPP”). The ESPP is intended to qualify as an “employee stock purchase plan” under Section 423 of the Internal Revenue Code and has been allocated 5,000,000 shares. The purchase price will be 95% of the Fair Market Value (as defined in the ESPP) of our common stock on the purchase date, and in any event will never be lower than the lower of 85% of the Fair Market Value of our common stock on the grant date or the purchase date. For the offering period that began on October 1, 2020 and ended December 31, 2020, participants purchased 62 thousand shares at a price of $22.88 per share.

Note 14 – Segment Information

We operate based on two reportable segments: (1) Defense and Intelligence, and (2) Civilian and Health Care. Our reportable segments and their respective operations are defined as follows:

Defense and Intelligence

Through its Defense and Intelligence business, Perspecta provides cybersecurity, data analytics, digital transformation, information technology modernization, and agile software development as well as technology to support intelligence, surveillance, and reconnaissance services to the DoD, intelligence community, branches of the U.S. Armed Forces, and other DoD agencies.

Key competitive differentiators for the Defense and Intelligence segment include global scale, solution objectivity, depth of industry expertise, strong partnerships, vendor and product independence and end-to-end solutions and capabilities. Evolving business demands such as globalization, fast-developing economies, government regulation and growing concerns around risk, security, and compliance drive demand for these offerings.

Civilian and Health Care

Through its Civilian and Health Care business, Perspecta provides enterprise IT transformation and modernization, application development and modernization, enterprise security, risk decision support, operations and sustainment, systems engineering, applied research, cyber services, and cloud transformation to the Departments of Homeland Security, Justice, and Health and Human Services, as well as other federal civilian and state and local government agencies.

Table of Contents

Segment Measures

The following tables summarize operating results regularly provided to the chief operating decision maker by reportable segment:


	Fiscal Quarter Ended				Three Fiscal Quarters Ended
(in millions)	January 1, 2021		December 31, 2019		January 1, 2021		December 31, 2019
Revenue
Defense and Intelligence	$	795	$	813	$	2,367	$	2,342
Civilian and Health Care	339		313		1,017		1,063
Total revenue	$	1,134	$	1,126	$	3,384	$	3,405
Segment profit
Defense and Intelligence	$	105	$	115	$	294	$	346
Civilian and Health Care	43		39		112		112
Total segment profit	$	148	$	154	$	406	$	458
Depreciation and amortization
Defense and Intelligence	$	24	$	27	$	73	$	76
Civilian and Health Care	9		11		31		55
Amortization of acquired intangible assets	60		54		181		152
Total depreciation and amortization	$	93	$	92	$	285	$	283

Reconciliation of Reportable Segment Profit to the Statements of Operations

The Company’s management uses segment profit as the measure for assessing performance of its segments. Segment profit is defined as segment revenue less segment cost of services, selling, general and administrative and depreciation and amortization, excluding certain operating expenses managed at the corporate level. These unallocated costs include certain corporate function costs, share-based compensation expense, amortization of acquired intangible assets, impairment charges, certain nonrecoverable restructuring costs, separation, transaction and integration-related costs, net periodic benefit cost and gain or loss on sale of assets.


	Fiscal Quarter Ended				Three Fiscal Quarters Ended
(in millions)	January 1, 2021		December 31, 2019		January 1, 2021		December 31, 2019
Total segment profit	$	148	$	154	$	406	$	458
Not allocated to segments:
Share-based compensation	(10)		(6)		(27)		(21)
Amortization of acquired intangible assets	(60)		(54)		(181)		(152)
Restructuring costs	(2)		—		(33)		(4)
Separation, transaction and integration-related costs	(7)		(20)		(34)		(59)
Interest expense, net	(28)		(34)		(87)		(105)
Other income and (expense), net	4		35		23		37
Income before taxes	$	45	$	75	$	67	$	154

Management does not use total assets by segment to evaluate segment performance or allocate resources. As a result, assets are not tracked by segment and therefore, total assets by segment is not disclosed.

Note 15 – Commitments and Contingencies

The Company is a party to or has responsibility under various lawsuits, claims, investigations and proceedings involving disputes or potential disputes related to commercial, employment and regulatory matters that arise in the ordinary course of business. The Separation and Distribution Agreement (the “SDA”) between Perspecta and DXC includes provisions that allocate liability and financial responsibility for litigation involving DXC and the Company and that provide for cross-indemnification of the parties for liabilities a party may incur that are allocated to the other party under the SDA. In

Table of Contents

addition, under the SDA, DXC and the Company have agreed to cooperate with each other in managing litigation that relates to both parties’ businesses. The SDA also contains provisions that allocate liability and financial responsibility for such litigation. The Company records a liability when it believes that it is both probable that a liability has been incurred and the amount of loss can be reasonably estimated. Significant judgment is required to determine both the probability of having incurred a liability and the estimated amount of the liability. The Company reviews these matters at least quarterly and adjusts these liabilities to reflect the impact of negotiations, settlements, rulings, advice of legal counsel and other updated information and events pertaining to a particular matter. Litigation is inherently unpredictable. However, the Company believes it has valid defenses with respect to legal matters pending against it. Nevertheless, cash flows or results of operations could be materially affected in any particular period by the resolution of one or more of these contingencies. The Company believes it has recorded adequate provisions for any such matters and, as of January 1, 2021, it was not reasonably possible that a material loss had been incurred in connection with such matters in excess of the amounts recognized in its financial statements.

Litigation, Proceedings and Investigations

Forsyth, et al. v. HP Inc. and Hewlett Packard Enterprise: This purported class and collective action was filed on August 18, 2016 in the U.S. District Court for the Northern District of California, against HP Inc. and HPE alleging violations of the Federal Age Discrimination in Employment Act (“ADEA”), the California Fair Employment and Housing Act, California public policy and the California Business and Professions Code. Plaintiffs filed an amended complaint on December 19, 2016. Plaintiffs are seeking to certify a nationwide class action under the ADEA comprised of certain U.S. residents employed by defendants who had their employment terminated pursuant to a work force reduction (“WFR”) plan on or after December 9, 2014 (deferral states) and April 8, 2015 (non-deferral states), and who were 40 years of age or older at the time of termination. Plaintiffs also seek to represent a Rule 23 class under California law comprised of certain persons 40 years or older employed by defendants in the state of California and terminated pursuant to a WFR plan on or after August 18, 2012. Two mediation sessions have taken place. In October 2018, a settlement was reached with 16 named and opt-in plaintiffs; that settlement has been completed. On June 26-27, 2019, a second mediation was held, involving 145 opt-in plaintiffs. On December 23, 2019, a settlement was reached with 142 of the 145 opt-in plaintiffs; that settlement also has been completed. On December 30, 2020, the plaintiffs filed a motion seeking to conditionally certify the collectives. Former business units of HPE now owned by the Company will be liable in this matter for any recovery by plaintiffs previously associated with the USPS business of HPE.

In addition to the matter noted above, the Company is currently subject in the normal course of business to various claims and contingencies arising from, among other things, disputes with customers, vendors, employees, contract counter parties and other parties, and inquiries and investigations by regulatory authorities and government agencies. Some of these disputes involve or may involve litigation. The financial statements reflect the treatment of claims and contingencies based on management’s view of the expected outcome. The Company consults with outside legal counsel on issues related to litigation and regulatory compliance and seeks input from other experts and advisors with respect to matters in the ordinary course of business. Although the outcome of these and other matters cannot be predicted with certainty, and the impact of the final resolution of these and other matters on the Company’s results of operations in a particular subsequent reporting period could be material and adverse, management does not believe, based on information currently available to the Company, that the resolution of any of the matters currently pending against the Company will have a material adverse effect on the financial position of the Company or the ability of the Company to meet its financial obligations as they become due. Unless otherwise noted, the Company is unable to determine at this time a reasonable estimate of a possible loss or range of losses associated with the foregoing disclosed contingent matters.

Commitments

In connection with the Spin-Off, the Company was obligated to purchase or license from DXC a specified amount of products and services each year for a two-year period ending July 31, 2020 (“Annual Minimum Purchase Amounts”). If the Company, however, had not met or exceeded the Annual Minimum Purchase Amounts by that date, it was required to pay DXC the amount of the shortfall. The combined two-year Annual Minimum Purchase Amounts commitment totaled approximately $141 million. In October 2019, the Company submitted a demand for arbitration claiming, among other things, that DXC breached its obligations under the relevant Spin-Off agreements by failing to properly apply credit against the Annual Minimum Purchase Amounts for eligible items purchased by the Company. That dispute relating to the appropriate crediting of eligible purchases involves approximately half of the total two-year Annual Minimum Purchase Amounts. The relevant agreements require such disagreements to be treated in a confidential manner through executive escalation, mediation and binding arbitration. Based on the status of the arbitration, we currently are unable to predict the impact of any resolution of this matter. Notwithstanding the arbitration claims, the Company would be obligated to pay

Table of Contents

DXC any amount of shortfall not addressed in or otherwise subject to the arbitration or covered by other possible defenses.

Guarantees

The Company uses stand-by letters of credit, in lieu of cash, to support various risk management insurance policies, which are cash collateralized. These letters of credit represent a contingent liability and the Company would only be liable if it defaults on its payment obligations on these policies. The Company’s stand-by letters of credit outstanding were less than $1 million as of January 1, 2021. As of January 1, 2021, the Company had $40 million in outstanding surety bonds, of which $7 million expire in fiscal year 2021, and $33 million expire in fiscal year 2022.

Note 16 – Subsequent Events

On January 27, 2021, the Company entered into the Agreement and Plan of Merger (the “Merger Agreement”) with Jaguar ParentCo Inc. (“Parent”) and Jaguar Merger Sub Inc. (“Merger Sub”). Pursuant to the Merger Agreement, subject to the satisfaction or waiver of specified conditions, the Company will be acquired by Peraton, a portfolio company of Veritas Capital Fund Management, L.L.C (“Veritas”), by Merger Sub merging with and into the Company (the “Merger”), with the Company surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger, each of the Company's issued and outstanding shares of common stock, par value $0.01 per share, will be cancelled and extinguished and converted into the right to receive $29.35 in cash, without interest, less any applicable withholding taxes. If the Merger Agreement is terminated under certain specified circumstances, we will be required to pay Parent a termination fee of $97,013,974 (including in connection with our entry into an agreement with respect to a Company Superior Proposal, as defined in the Merger Agreement, if certain conditions are met). The consummation of the Merger remains subject to customary closing conditions, including approval of the Merger Agreement by our stockholders. As a result of the Merger, the Company will cease to be a publicly traded company at the effective time of the Merger. The foregoing description of the Merger Agreement is not complete and is qualified in its entirety by reference to the Merger Agreement, which is included as Exhibit 2.1 to this Quarterly Report on Form 10-Q.

Following the announcement of the Merger, the Company plans to terminate the offering period beginning January 1, 2021 and ending March 31, 2021 under the ESPP, and accumulated amounts withheld from the employees during that offering period will be refunded. Future offerings are suspended until further notice.

Table of Contents

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

All statements and assumptions contained in this Quarterly Report on Form 10-Q and in the documents incorporated by reference that do not directly and exclusively relate to historical facts could be deemed “forward-looking statements.” Forward-looking statements are often identified by the use of words such as “anticipates,” “believes,” “estimates,” “expects,” “may,” “could,” “should,” “forecast,” “goal,” “intends,” “objective,” “plans,” “projects,” “strategy,” “target” and “will” and similar words and terms or variations of such. These statements represent current expectations and beliefs, and no assurance can be given that the results described in such statements will be achieved.

Forward-looking statements include, among other things, statements with respect to our financial condition, results of operations, cash flows, business strategies, prospects, operating efficiencies or synergies, competitive position, growth opportunities, share repurchases, dividend payments, plans and objectives of management and other matters. Such statements are subject to numerous assumptions, risks, uncertainties and other factors that could cause actual results to differ materially from those described in such statements, many of which are outside of our control. Important factors that could cause actual results to differ materially from those described in forward-looking statements include, but are not limited to:

•potential disruptions to our business caused by the proposed acquisition of us by Peraton, a portfolio company of Veritas:

•failure to complete the Merger in a timely manner or at all;

•various risks related to health epidemics, pandemics and similar outbreaks, such as the COVID-19 pandemic, which may have material adverse effects on our business, financial position, results of operations and/or cash flows;

•any issue that compromises our relationships with the U.S. federal government, or any state or local governments, or damages our professional reputation;

•changes in the U.S. federal, state and local governments’ spending and mission priorities that shift expenditures away from agencies or programs that we support;

•any delay in completion of the U.S. federal government’s budget process;

•failure to comply with numerous laws, regulations and rules, including regarding procurement, anti-bribery and organizational conflicts of interest;

•failure by us or our employees to obtain and maintain necessary security clearances or certifications;

•our ability to compete effectively in the competitive bidding process and delays, contract terminations or cancellations caused by competitors’ protests of major contract awards received by us;

•our ability to accurately estimate or otherwise recover expenses, time and resources for our contracts;

•problems or delays in the development, delivery and transition of new products and services or the enhancement of existing products and services to meet customer needs and respond to emerging technological trends;

•failure of third parties to deliver on commitments under contracts with us;

•misconduct or other improper activities from our employees or subcontractors;

•delays, terminations or cancellations of our major contract awards, including as a result of our competitors

protesting such awards;

•failure of our internal control over financial reporting to detect fraud or other issues;

•failure or disruptions to our systems, due to cyber-attack, service interruptions or other security threats;

•failure to be awarded task orders under our indefinite delivery/indefinite quantity (“ID/IQ”) contracts;

•changes in government procurement, contract or other practices or the adoption by the government of new laws, rules and regulations in a manner adverse to us;

•uncertainty from the expected discontinuance of the London Interbank Offered Rate (“LIBOR”) and transition to any other interest rate benchmark; and

•the other factors described in Part I, Item 1A “Risk Factors” of Perspecta’s Annual Report on Form 10-K for the fiscal year ended March 31, 2020.

There may be other factors that may cause our actual results to differ materially from the forward-looking statements, including factors disclosed under the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” herein and in other information we publicly disclose from time to time. You should evaluate all forward-looking statements made in this Quarterly Report on Form 10-Q in the context of these risks and uncertainties. Our public filings may be accessed through our investor relations website, https://investors.perspecta.com, or through the website maintained by the SEC at https://www.sec.gov.

Table of Contents

No assurance can be given that any expectation, goal or plan set forth in any forward-looking statement can or will be achieved, and readers are cautioned not to place undue reliance on such statements which speak only as of the date they are made. We do not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date of this Quarterly Report on Form 10-Q or to reflect the occurrence of unanticipated events, except as required by law.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis is intended to help investors understand our business, financial condition, results of operations, liquidity and capital resources. This discussion should be read in conjunction with the financial statements and related notes included elsewhere in this document and with our Annual Report on Form 10-K for the fiscal year ended March 31, 2020.

The statements in this discussion regarding industry outlook, expectations regarding our future performance, liquidity and capital resources and other non-historical statements are forward-looking statements. These forward-looking statements are subject to numerous risks and uncertainties, including, but not limited to, the risks and uncertainties described in “Risk Factors” and “Cautionary Statement Regarding Forward-Looking Statements.” Some of these risks and uncertainties include, but are not limited to, the risk factors set forth in our Annual Report on Form 10-K for the fiscal year ended March 31, 2020, as updated periodically through our subsequent quarterly reports on Form 10-Q. Actual results may differ materially from those contained in any forward-looking statements.

Overview

We are a leading provider of end-to-end enterprise IT services to government customers across U.S. federal, state and local markets. Using our market-leading enterprise offerings and solutions, we help our government customers implement modern collaborative workplaces, hybrid cloud platforms and integrated digital systems of engagement with their enterprise management systems. By delivering these modern enterprise solutions, often while ensuring interoperability with mission critical legacy systems, we believe we have helped our government customers better realize the benefits of technology, which will ultimately enable them to fulfill their mission objectives and achieve their desired business outcomes.

In addition to providing substantial benefits through increased efficiencies and capabilities, we believe demand for our services is also driven by the technological advances that already reinvented commercial industries, which are now exerting a similar evolutionary effect on government customers. In response to these pressures, we believe government customers are increasingly turning to outside partners, such as Perspecta, to help guide them through their digital transformation.

We believe our breadth of contracts and customers in the U.S. government, and our longstanding history of having partnered with our public sector customers for more than 50 years via our legacy companies, provides us with a competitive advantage. For example, we have existing contracts with a range of public sector entities including the DoD, the U.S. Department of Veterans Affairs, to the U.S. Postal Service, the U.S. Food and Drug Administration and large state and local government customers such as the county of San Diego, California. Based on this breadth of experience and our expertise, we believe we are well positioned to help our U.S. government customers continue their ongoing digital transformation journey.

Perspecta became an independent company following consummation of the Spin-Off from DXC on May 31, 2018. On October 29, 2019, the Company filed for arbitration against DXC to resolve certain disputed items related to the Spin-Off. After completion of the Spin-Off, the Company began assessing the respective rights, responsibilities and obligations of DXC and the Company under the SDA and other related Spin-Off agreements. Based on this assessment, and in accordance with the provisions of the agreements, the Company disputed certain transactions that were effected by DXC in connection with the Spin-Off. The Company has been addressing these matters with DXC pursuant to the terms of the SDA, including its confidentiality provisions and dispute resolution provisions that require executive escalation, mediation and binding arbitration. Based on the status of the arbitration, we currently are unable to predict the impact of any resolutions of these matters on the Company.

Table of Contents

Recent Developments

On January 27, 2021, we entered into the Merger Agreement with Parent and Merger Sub. Pursuant to the Merger Agreement, subject to the satisfaction or waiver of specified conditions, we will be acquired by Peraton, a portfolio company of Veritas, by means of the Merger, which consists of Merger Sub merging with and into the Company, with the Company surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger, each of our issued and outstanding shares of common stock, par value $0.01 per share, will be cancelled and extinguished and converted into the right to receive $29.35 in cash, without interest, less any applicable withholding taxes. If the Merger Agreement is terminated under certain specified circumstances, we will be required to pay Parent a termination fee of $97,013,974 (including in connection with our entry into an agreement with respect to a Company Superior Proposal, as defined in the Merger Agreement, if certain conditions are met). The consummation of the Merger remains subject to customary closing conditions, including approval of the Merger Agreement by our stockholders. As a result of the Merger, we will cease to be a publicly traded company at the effective time of the Merger. The foregoing description of the Merger Agreement is not complete and is qualified in its entirety by reference to the Merger Agreement, which is included as Exhibit 2.1 to this Quarterly Report on Form 10-Q.

Acquisition

On May 1, 2020, Perspecta completed the acquisition of DHPC, a U.S. developer of electronic warfare technologies with market-leading technical solutions and a solid, proven reputation with Army customers. The purchase consideration was approximately $53 million in cash. See Note 3 – “Acquisitions” to the financial statements for additional details.

Segments and Services

Our reportable segments are (1) Defense and Intelligence, which provides services to the DoD, intelligence community, branches of the U.S. Armed Forces, and other DoD agencies, and (2) Civilian and Health Care, which provides services to the Departments of Homeland Security, Justice, and Health and Human Services, as well as other federal civilian and state and local government agencies. Segment information is included in Note 14 – “Segment Information” to the financial statements.

Backlog

Total contract value (“TCV”) backlog is our estimate of the remaining revenue from existing signed contracts, assuming the exercise of all options relating to such contracts and including executed task orders issued under ID/IQ contracts. TCV backlog can include award fees, incentive fees, or other variable consideration estimated at the most likely amount to which the Company is expected to be entitled to the extent that it is probable that a significant reversal of cumulative revenue recognized will not occur. TCV backlog includes both funded and unfunded future revenue under government contracts.

We define funded backlog as estimated future revenue under government contracts and task orders for which funding has been appropriated by Congress and authorized for expenditure by the applicable agency. Funded backlog does not include the full potential value of the Company’s contracts because Congress often appropriates funds to be used by an agency for a particular program of a contract on a yearly or quarterly basis even though the contract may call for performance over a number of years. As a result, contracts typically are only partially funded at any point during their term, and all or some of the work to be performed under the contracts may remain unfunded unless and until Congress makes subsequent appropriation and the procuring agency allocates funding to the contract.

A variety of circumstances or events may cause changes in the amount of our TCV backlog and funded backlog, including the execution of new contracts, the extension of existing contracts, the non-renewal or completion of current contracts, the early termination of contracts, and adjustment to estimates for previously included contracts. Changes in the amount of our funded backlog also are affected by the funding cycles of the government.

The estimated value of our TCV backlog as of January 1, 2021 was as follows:


(in millions)	Funded Backlog		Unfunded Backlog		Total TCV Backlog
Defense and Intelligence	$	1,069	$	7,424	$	8,493
Civilian and Health Care	625		4,447		5,072
Total backlog	$	1,694	$	11,871	$	13,565

The contract awards during the fiscal quarters and three fiscal quarters ended January 1, 2021 and December 31, 2019 were as follows:


	Fiscal Quarter Ended				Three Fiscal Quarters Ended
(in millions)	January 1, 2021		December 31, 2019		January 1, 2021		December 31, 2019
Defense and Intelligence	$	744	$	515	$	2,626	$	3,118
Civilian and Health Care	120		1,097		1,184		1,801
Total contract awards	$	864	$	1,612	$	3,810	$	4,919

Results of Operations

Impact of the COVID-19 Pandemic

The fourth quarter of fiscal year 2020 marked the beginning of the COVID-19 pandemic in the United States, and the pandemic has continued through the third quarter of fiscal year 2021. Due to the mission-critical nature of the majority of our business, substantially all of the services we provide to our government customers have been considered essential services, which has allowed them to continue, and the Company has maintained its workforce near full capacity. The overall impact of the COVID-19 pandemic on our results of operations was approximately $19 million and $60 million of lower revenue for the fiscal quarter and three fiscal quarters ended January 1, 2021, respectively, and a year-to-date liquidity benefit of $57 million due to deferral of payroll tax payments as afforded by the Coronavirus Aid, Relief and Economic Security (“CARES”) Act, discussed below. We continue to assess further possible implications to our business, supply chain and customers, and to take actions in an effort to mitigate adverse consequences.

We are continuing to monitor the ongoing COVID-19 pandemic. We have experienced and expect to continue to experience certain disruptions in our operations and impact to our workforce and subcontractor workforce due to illness, quarantines, shelter-in-place orders, closures of our facilities, closures of our customers’ facilities and other restrictions or government actions in connection with the COVID-19 pandemic. At the outset of the pandemic, we deployed our Crisis and Business Continuity Plan, which provides an integrated and coordinated crisis management and continuity of operations framework for all personnel during a crisis, and we have implemented new protocols including telework or other means of remote work for our employees. With respect to our impacted programs that, by their nature, cannot be supported remotely, we have accommodated those customers who have implemented shiftwork or other mitigation protocols by maintaining our workforce in a “mission ready” state such that the workforce is able to mobilize in a timely manner.

On March 27, 2020, the CARES Act was enacted. The CARES Act is a $2 trillion stimulus package meant to combat the economic impacts of the COVID-19 pandemic. The CARES Act includes a provision under which government contractors can seek reimbursement for amounts related to keeping the employee base in a ready state during disruptions such as closed facilities, reduced work schedules or mandated quarantines to support social distancing. In these situations, we are able to recover our costs associated with this ready state workforce, but we are not able to bill any associated fee. The relevant provision of the CARES Act has been extended through March 31, 2021. We continue to evaluate this and other provisions of the CARES Act, as well as any other legislative or regulatory initiatives that seek to address the impact of the COVID-19 pandemic on our business.

For additional discussion of the risks associated with the COVID-19 pandemic, see Part I, Item 1A “Risk Factors” of our

Annual Report on Form 10-K for the fiscal year ended March 31, 2020.

Table of Contents

Selected Results of Operations

Selected financial information is presented in the tables below:


	Fiscal Quarter Ended				Change
(in millions, except per share amounts)	January 1, 2021		December 31, 2019		$		%
Revenue	$	1,134	$	1,126	$	8	1	%
Total costs and expenses	1,089		1,051		38		4	%
Income before income taxes	45		75		(30)		(40)	%
Income tax expense	14		22		(8)		(36)	%
Net income	$	31	$	53	$	(22)	(42)	%

Diluted earnings per share	$	0.19	$	0.33


	Three Fiscal Quarters Ended				Change
(in millions, except per share amounts)	January 1, 2021		December 31, 2019		$		%
Revenue	$	3,384	$	3,405	$	(21)	(1)	%
Total costs and expenses	3,317		3,251		66		2	%
Income before income taxes	67		154		(87)		(56)	%
Income tax expense	23		41		(18)		(44)	%
Net income	$	44	$	113	$	(69)	(61)	%

Diluted earnings per share	$	0.27	$	0.69

Revenue

Revenue by segment for the fiscal quarter and three fiscal quarters ended January 1, 2021 and December 31, 2019 was:


	Fiscal Quarter Ended				Change
(in millions)	January 1, 2021		December 31, 2019		$		%
Defense and Intelligence	$	795	$	813	$	(18)	(2)	%
Civilian and Health Care	339		313		26		8	%
Total	$	1,134	$	1,126	$	8	1	%



	Three Fiscal Quarters Ended				Change
(in millions)	January 1, 2021		December 31, 2019		$		%
Defense and Intelligence	$	2,367	$	2,342	$	25	1	%
Civilian and Health Care	1,017		1,063		(46)		(4)	%
Total	$	3,384	$	3,405	$	(21)	(1)	%

Defense and Intelligence Segment

Our Defense and Intelligence segment revenue during the fiscal quarter ended January 1, 2021 decreased by $18 million, or 2%, as compared to the comparable period of the prior year primarily due to lower volume, including revenue lost as a result of COVID-19. Our Defense and Intelligence segment revenue during the three fiscal quarters ended January 1, 2021 increased by $25 million, or 1%, as compared to the comparable period of the prior year primarily due to the ramp up of new business wins coupled with growth on existing programs, partially offset by revenue lost as a result of COVID-19.

Table of Contents

Civilian and Health Care Segment

Our Civilian and Health Care segment revenue during the fiscal quarter ended January 1, 2021 increased by $26 million, or 8%, as compared to the comparable period of the prior year primarily due to the ramp up of new program wins and growth on existing programs. Our Civilian and Health Care segment revenue during the three fiscal quarters ended January 1, 2021 decreased by $46 million, or 4%, as compared to the comparable period of the prior year primarily due to the completion or wind down of programs and a reduced level of effort on certain programs, partially offset by the ramp up of new program wins.

Costs and Expenses

Our total costs and expenses are shown in the tables below:


	Fiscal Quarter Ended				Percentage of Revenue				Change
(in millions)	January 1, 2021		December 31, 2019		January 1, 2021		December 31, 2019		$		%
Costs of services	$	906	$	863	80	%	77	%	$	43	5	%
Selling, general and administrative	57		77		5	%	7	%	(20)		(26)	%
Depreciation and amortization	93		92		8	%	8	%	1		1	%
Restructuring costs	2		—		—	%	—	%	2		NM
Separation, transaction and integration-related costs	7		20		1	%	2	%	(13)		(65)	%
Interest expense, net	28		34		2	%	3	%	(6)		(18)	%
Other (income) expense, net	(4)		(35)		—	%	(3)	%	31		(89)	%
Total costs and expenses	$	1,089	$	1,051	96	%	93	%	$	38	4	%



	Three Fiscal Quarters Ended				Percentage of Revenue				Change
(in millions)	January 1, 2021		December 31, 2019		January 1, 2021		December 31, 2019		$		%
Costs of services	$	2,717	$	2,607	80	%	77	%	$	110	4	%
Selling, general and administrative	184		230		5	%	7	%	(46)		(20)	%
Depreciation and amortization	285		283		8	%	8	%	2		1	%
Restructuring costs	33		4		1	%	—	%	29		725	%
Separation, transaction and integration-related costs	34		59		1	%	2	%	(25)		(42)	%
Interest expense, net	87		105		3	%	3	%	(18)		(17)	%
Other (income) expense, net	(23)		(37)		(1)	%	(1)	%	14		(38)	%
Total costs and expenses	$	3,317	$	3,251	98	%	95	%	$	66	2	%

Costs of Services

For the fiscal quarter ended January 1, 2021, costs of services as a percentage of revenue was 80%, as compared to 77% for the comparable period of the prior year. For the three fiscal quarters ended January 1, 2021, cost of services as a percentage of revenue was 80%, as compared to 77% for the comparable period of the prior year. Margins were negatively impacted by the inability to bill fee on our mission ready workforce idled by the COVID-19 pandemic, the completion and wind down of certain fixed price programs, lower volumes and start-up costs associated with new contract wins, partially offset by continued focus on cost discipline and program management of our portfolio. Our cost-reimbursable and time-and-materials contracts typically have consistent margins, whereas the margin on our fixed price contracts is dependent upon management’s ability to control the costs of providing the services. We expect our contract mix to remain relatively stable over the long term.

Table of Contents

Selling, General and Administrative

Selling, general and administrative expense (“SG&A”) was $57 million for the fiscal quarter ended January 1, 2021, as compared to $77 million for the comparable period of the prior year. SG&A as a percentage of revenue for the fiscal quarter ended January 1, 2021 was 5%, as compared to 7% for the comparable period of the prior year, with the decrease in the current fiscal year primarily due to reduced costs as a result of restructuring activities in prior quarters, and indirect cost management. SG&A was $184 million for the three fiscal quarters ended January 1, 2021, as compared to $230 million for the comparable period of the prior year. SG&A as a percentage of revenue for the three fiscal quarters ended January 1, 2021 was 5%, as compared to 7% for the comparable period of the prior year, with the decrease in the current fiscal year primarily due to indirect cost management and reduced costs as a result of restructuring activities taken in fiscal year 2020.

Depreciation and Amortization

Depreciation and amortization expense was $93 million for the fiscal quarter ended January 1, 2021, as compared to $92 million for the comparable period of the prior year. Depreciation and amortization expense was $285 million for the three fiscal quarters ended January 1, 2021, as compared to $283 million for the comparable period of the prior year.

Restructuring Costs

During the fiscal quarter ended January 1, 2021, restructuring activities resulted in costs of $2 million, as compared to $0 million during the comparable period of the prior year. During the three fiscal quarters ended January 1, 2021, restructuring activities resulted in costs of $33 million, as compared to $4 million during the comparable period of the prior year. See Note 10 – “Leases” for a description of the facility rationalization restructuring plan that has been executed throughout the first three fiscal quarters of fiscal year 2021.

Interest Expense, Net

Interest expense, net for the fiscal quarter ended January 1, 2021 was $28 million, as compared to $34 million during the comparable period of the prior year. The decrease of $6 million in interest expense for the fiscal quarter ended January 1, 2021 was primarily attributed to a lower LIBOR rate during the current period. Interest expense, net for the three fiscal quarters ended January 1, 2021 was $87 million, as compared to $105 million during the comparable period of the prior year. The decrease of $18 million in interest expense for the three fiscal quarters ended January 1, 2021 was primarily attributed to a lower LIBOR rate during the current period.

Other (Income) Expense, Net

Other (income) expense, net for the fiscal quarter ended January 1, 2021 was $(4) million, as compared to $(35) million during the comparable period of the prior year, and $(23) million for the three fiscal quarters ended January 1, 2021, as compared to $(37) million during the comparable period of the prior year. Other (income) expense, net for the three fiscal quarters ended January 1, 2021 included a $8 million reduction of a DXC indemnification liability related to an income tax receivable. The corresponding income tax receivable was reduced by the same amount, resulting in a $8 million increase to income tax expense as discussed below. Other (income) expense, net for the fiscal quarter and three fiscal quarters ended December 31, 2019 included a net gain on sale and leaseback transactions of $33 million related to the sale of assets. Other (income) expense, net for the three fiscal quarters ended December 31, 2019 also included a $7 million reduction of a DXC indemnification receivable related to a liability for unrecognized tax benefits. The corresponding tax reserves were reduced by the same amount, resulting in a $7 million reduction of income tax expense in accordance with ASC Topic 740, Income Taxes. Other (income) expense, net for both the fiscal quarter and three fiscal quarters ended January 1, 2021 and December 31, 2019 also included certain components of the net periodic pension cost for defined benefit pension plans, equity in earnings of unconsolidated affiliates and other miscellaneous gains and losses.

Table of Contents

Taxes

Income tax expense was $14 million and $23 million for the fiscal quarter and three fiscal quarters ended January 1, 2021, respectively, as compared to $22 million and $41 million for the comparable period of the prior year. The ETR was approximately 31% and 34% for the fiscal quarter and three fiscal quarters ended January 1, 2021, respectively, as compared to 29% and 27% for the fiscal quarter and three fiscal quarters ended December 31, 2019, respectively. Tax expense for the three fiscal quarters ended January 1, 2021 and December 31, 2019 included an expense of $8 million and a benefit of $7 million, respectively, from the adjustment of tax reserves discussed above. For the fiscal quarter and three fiscal quarters ended January 1, 2021, the primary drivers of our ETR were state income taxes, adjustments to indemnified taxes receivable and limitations on executive compensation deductions. For the fiscal quarter and three fiscal quarters ended December 31, 2019, the primary drivers of our ETR were state income taxes, including a valuation allowance against a state interest deduction limit carryforward.

The Company is subject to income taxes in the U.S. (federal and state). Significant judgment is required in determining the provision for income taxes, analyzing the income tax reserves and the determination of the likelihood of recoverability of deferred tax assets and adjustment of valuation allowances. In addition, the Company’s tax returns are routinely audited, and settlements of issues raised in these audits sometimes affect the tax provisions. Potential liabilities or refunds resulting from these audits are covered by the TMA between Perspecta and DXC.

The TMA with DXC governs the respective rights, responsibilities and obligations of DXC and the Company after the Spin-Off with respect to all tax matters and includes restrictions designed to preserve the tax-free status of the Distribution (as defined in the SDA). As a subsidiary of DXC, the Company had (and the Company continues to have following the Spin-Off) several liability to the IRS for the full amount of the consolidated U.S. federal income taxes of the DXC consolidated group relating to the taxable periods in which the Company was part of that group. However, the TMA specifies the portion, if any, of this tax liability for which the Company will bear responsibility. The Company agrees to indemnify DXC against any amounts for which the Company is responsible and DXC agrees to indemnify the Company against any amounts for which the Company is not responsible. The TMA also provides special rules for allocating tax liabilities in the event that the Spin-Off is not tax-free. The TMA provides for certain covenants that may restrict the ability of the Company to pursue strategic or other transactions that otherwise could maximize the value of the business and may discourage or delay a change of control. Pursuant to the TMA, the Company has agreed to indemnify DXC for any tax liabilities resulting from a breach of such covenants or certain other actions. Though valid as between the parties, the TMA will not be binding on the IRS.

Liquidity and Capital Resources

We pursue a cash management and capital deployment strategy that balances funding our current operating needs with growing our business. Existing cash and cash equivalents and cash generated by operations continue to be our primary sources of liquidity, as well as available borrowings under our Revolving Credit Facility (as defined in Note 10 – “Debt” to the financial statements of our Annual Report on Form 10-K for the fiscal year ended March 31, 2020) and sales of receivables under a U.S. federal government obligor receivables purchase facility established pursuant to the Master Accounts Receivable Purchase Agreement (“MARPA Facility”) (as defined in Note 5 – “Receivables” of our Annual Report on Form 10-K for the fiscal year ended March 31, 2020).

Our primary cash needs are expected to be for working capital, capital expenditures, acquisitions, the return of cash to shareholders through share repurchases and dividend payments, and other discretionary investments, as well as to service our outstanding indebtedness, including borrowings under our Credit Facilities. Our ability to fund our future operating needs depends, in part, on our ability to continue to generate positive cash flows from operations and, if necessary, raise cash in the capital markets. Based upon our history of generating strong cash flows, it is our belief that we will be able to meet our short-term liquidity and cash needs, including debt servicing, through the combination of cash flows from operating activities, available cash balances, available borrowings under our Revolving Credit Facility and sales of receivables under our MARPA Facility. If these sources of liquidity need to be augmented, additional cash requirements would likely be financed through the issuance of debt or equity securities, although there can be no assurance that we will able to obtain such financing on acceptable terms (or at all) in the future.

In July 2017, the Financial Conduct Authority (the authority that regulates LIBOR) announced it intends to stop compelling banks to submit rates for the calculation of LIBOR after June 2023 for rates applicable to our debt. The Alternative Reference Rates Committee (“ARRC”) has proposed that the Secured Overnight Financing Rate (“SOFR”) is the rate that represents best practice as the alternative for use in derivatives and other financial contracts that are currently indexed to LIBOR. ARRC has proposed a paced market transition plan to SOFR from LIBOR and organizations are currently working

Table of Contents

on industry wide and company specific transition plans as it relates to derivatives and cash markets exposed to LIBOR. The Company has material contracts that are indexed to LIBOR and is continuing to monitor this activity and evaluate the related risks.

Our exposure to operational liquidity risk is primarily from long-term contracts which require significant investment of cash during the initial phases of the contracts. The recovery of these investments is over the life of the contract and is dependent upon our performance as well as customer acceptance.

See Note 15 – “Commitments and Contingencies” to the financial statements for discussion of the general purpose of guarantees and commitments.

The anticipated sources of funds to fulfill such commitments are listed below:



(in millions)	January 1, 2021
Cash and cash equivalents	$	224
Available borrowings under our Revolving Credit Facility	750
Total liquidity	$	974

Cash and Cash Equivalents and Cash Flows

As of January 1, 2021, our cash and cash equivalents were $224 million. Cash and cash equivalents increased $77 million, as compared to $147 million at March 31, 2020, driven by cash flow generation through working capital management.

The following table summarizes our cash flow activity:


	Three Fiscal Quarters Ended
(in millions)	January 1, 2021		December 31, 2019		Change
Net cash provided by operating activities	$	413	$	440	$	(27)
Net cash used in investing activities	(75)		(203)		128
Net cash used in financing activities	(293)		(208)		(85)
Net change in cash and cash equivalents, including restricted	45		29		16
Cash and cash equivalents, including restricted, at beginning of period	221		99		122
Cash and cash equivalents, including restricted, at end of period	266		128		138
Less restricted cash and cash equivalents included in other current assets	42		59		(17)
Cash and cash equivalents at end of period	$	224	$	69	$	155

Net cash provided by operating activities during the three fiscal quarters ended January 1, 2021 was $413 million, as compared to $440 million during the comparable period of the prior year. The decrease of $27 million was impacted by a $69 million decrease in net income adjusted for noncash items, driven by lost revenue of approximately $60 million from the COVID-19 pandemic as discussed above, partially offset by $42 million of favorable movements in working capital primarily due to timing associated with accounts receivable and the deferral of payment of the employer portion of payroll tax afforded under the CARES Act.

Net cash used in investing activities during the three fiscal quarters ended January 1, 2021 was $75 million, as compared to $203 million during the comparable period of the prior year. The decrease was primarily due to the current year period acquisition of DHPC compared to the larger acquisition of Knight Point in the prior year period, as discussed in Note 3 – “Acquisitions” to the financial statements.

Net cash used in financing activities during the three fiscal quarters ended January 1, 2021 was $293 million, as compared to $208 million during the comparable period of the prior year. In the comparable period of the prior year, $175 million was drawn on the Revolving Credit Facility to partially finance the acquisition of Knight Point, which was offset by routine financing transactions, including lease payments, share repurchases and dividend payments. We repaid $50 million of our Revolving Credit Facility and made unscheduled payments on our senior secured credit facilities during the three fiscal quarters ended January 1, 2021 and incurred routine financing transactions, including lease payments and

Table of Contents

dividend payments. No common shares were repurchased under the Company’s share repurchase program during the three fiscal quarters ended January 1, 2021. At January 1, 2021, our $750 million Revolving Credit Facility remained unused.

Capital Resources

The following table summarizes our total debt:



(in millions)	January 1, 2021		March 31, 2020
Short-term debt and current maturities of long-term debt	$	90	$	89
Long-term debt, net of current maturities	2,123		2,283
Total debt	$	2,213	$	2,372

The decrease in total debt as of January 1, 2021, as compared to total debt as of March 31, 2020, resulted primarily from the $50 million payment on the Revolving Credit Facility and voluntary permanent principal payments. At January 1, 2021, $750 million was available under our Revolving Credit Facility. We were in compliance with all financial covenants associated with our borrowings as of January 1, 2021. For more information on our debt, see Note 9 – “Debt” to the financial statements.

The following table summarizes our capitalization ratios:



(in millions)	January 1, 2021			March 31, 2020
Total debt and finance leases	$	2,404		$	2,619
Cash and cash equivalents	224			147
Net debt(1)	$	2,180		$	2,472

Total debt and finance leases	$	2,404		$	2,619
Total shareholders’ equity	1,408			1,357
Total capitalization	$	3,812		$	3,976

Debt-to-total capitalization	63		%	66		%
Net debt-to-total capitalization(1)	57		%	62		%

(1) Net debt and net debt-to-total capitalization are non-GAAP measures used by management to assess our ability to service our debts using only our cash and cash equivalents. We present these non-GAAP measures to assist investors in analyzing our capital structure in a more comprehensive way compared to gross debt based ratios alone.

The reduction in debt-to-total capitalization and net debt-to-total capitalization as of January 1, 2021 compared with March 31, 2020 was driven by strong cash flows and the voluntary payment of debt principal, while meeting scheduled debt obligations and returning value to shareholders.

Interest Rate Swaps

We use interest rate swaps to manage the amount of our floating rate debt in order to reduce our exposure to variable rate interest payments associated with our floating interest rate debt. The interest rate swaps effectively convert our floating interest rate debt into fixed interest rate debt. Each swap agreement is designated as a cash flow hedge. We pay a stream of fixed interest payments for the term of the swap, and in turn, receive variable interest payments based on one-month LIBOR. At January 1, 2021, the one-month LIBOR rate applicable to the swap agreements was 0.15%. The net receipt or payment from the interest rate swap agreements is included in the statements of operations as interest expense.

Table of Contents

The following table summarizes our interest rate swaps at January 1, 2021:


Start Date	Maturity Date	Notional Amount (in millions)		Weighted Average Interest Rate Paid
May 2018	May 2021	$	400	2.57	%
May 2018	May 2022	500		2.61	%
October 2018	October 2022	200		2.92	%
May 2018	May 2023	500		2.68	%
Swaps in effect		1,600		2.66	%
May 2021	May 2024	400		0.50 %
May 2022	May 2025	500		0.69	%

Total Swaps		$	2,500

Cash Dividends and Share Repurchase Programs

On May 21, 2020, the Company increased the quarterly cash dividend on its common stock by 17% to $0.07 per common share from $0.06 per common share. The payment of future quarterly dividends is subject to approval by the Board of Directors. Due to the uncertainty and volatility of the financial markets resulting from the COVID-19 pandemic, we did not repurchase any of our common shares during the fiscal quarter ended January 1, 2021. However, our liquidity and financial flexibility are strong, and share repurchases will continue to be a key part of our capital deployment strategy. See Note 13 – “Shareholders’ Equity” to the financial statements for a discussion, including the amounts, of the cash returned to shareholders. For additional discussion of our share repurchase program, see Part II, Item 2 “Unregistered Sales of Equity Securities and Use of Proceeds.”

Off-Balance Sheet Arrangements

There have been no material changes to our off-balance sheet arrangements reported under Part II, Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our Annual Report on Form 10-K for the fiscal year ended March 31, 2020.

Contractual Obligations

There have been no material changes to our contractual obligations from those reported under Part II, Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our Annual Report on Form 10-K for the fiscal year ended March 31, 2020.

Critical Accounting Policies and Estimates

The preparation of consolidated financial statements in accordance with GAAP requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, as well as the disclosure of contingent assets and liabilities. These estimates may change in the future if underlying assumptions or factors change. Accordingly, actual results could differ materially from our estimates under different assumptions, judgments or conditions. We consider certain policies to be critical because of their complexity and the high degree of judgment involved in implementing them, including policies related to: revenue recognition, acquisition accounting, valuation of goodwill and income taxes. Our critical accounting policies and estimates are more fully discussed in Part II, Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our Annual Report on Form 10-K for the fiscal year ended March 31, 2020, under the heading “Critical Accounting Policies and Estimates.”

Valuation of Goodwill

In accordance with ASC Topic 350, Goodwill and Other Intangible Assets, the Company tests goodwill for impairment on an annual basis, as of the first day of the second fiscal quarter, and between annual tests if circumstances change, or if an event occurs that would more likely than not reduce the fair value of a reporting unit below its carrying amount. Factors which could necessitate an interim impairment assessment include, but are not limited to, a sustained decline in our stock

Table of Contents

price, significant decreases in federal government appropriations or funding for our contracts, the loss of significant business or significant underperformance relative to historical or projected future operating results.

Determining the fair value of a reporting unit is judgmental in nature and involves the use of significant estimates and assumptions that we believe are reasonable but inherently uncertain, and actual results may differ from those estimates. The Company engages a third-party valuation specialist to estimate the fair value of the reporting units using both an income approach and a market approach. The income approach incorporates the use of a discounted cash flow method in which the estimated future cash flows and terminal values for each reporting unit are discounted to a present value using a discount rate. Cash flow projections are based on management’s estimates of economic and market conditions, which drive key assumptions of revenue growth rates, operating income, capital expenditures, and working capital requirements. The results of these approaches are used to corroborate the conclusion.

Based on the results of the annual assessment, we concluded that no impairment of goodwill existed at July 4, 2020. As noted above, a significant decrease in cash flows or a loss of a significant contract would negatively impact the estimated fair value of a reporting unit and could necessitate an interim impairment assessment of goodwill associated with that reporting unit.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As disclosed in Part II, Item 7A “Quantitative and Qualitative Disclosures About Market Risk” of our Annual Report on Form 10-K for the fiscal year ended March 31, 2020, we actively monitor our exposures to potential loss arising from adverse changes in market rates and prices and manage such risks through our regular operating and financing activities or the use of derivative financial instruments. Our exposures to market and financial risk have not changed materially since March 31, 2020. See Note 7 – “Fair Value” and Note 8 – “Derivative Instruments” to the financial statements for additional discussion.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our chief executive officer (“CEO”) and chief financial officer (“CFO”), has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on that evaluation, our CEO and CFO concluded that, as of the end of the period covered by this Quarterly Report on Form 10-Q, our disclosure controls and procedures were effective to ensure that information required to be disclosed in the reports that we file or submit to the U.S. Securities and Exchange Commission (“SEC”) under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and (2) accumulated and communicated to management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.

Remediation Efforts to Address Material Weakness in Internal Control over Financial Reporting

As described more fully in Item 9A, “Controls and Procedures” of our Annual Report on Form 10-K for the fiscal year ended March 31, 2020, we identified a material weakness in our internal control over financial reporting in the area of revenue recognition that existed as of March 31, 2020. Since identifying the material weakness and prior to the quarter ended January 1, 2021, management took the following steps to address the underlying causes of the material weakness and remediate the material weakness:

•A new enterprise resource planning system, which is being utilized throughout the revenue recognition process, was implemented in April 2020.

•The Company added additional personnel with U.S. GAAP revenue recognition knowledge and experience.

•Additional revenue recognition training was provided to responsible staff.

•New policies and procedures, including standardized templates, were implemented to govern the execution and review of certain calculations for revenue recognition purposes.

•The Company enhanced controls over the revenue recognition checklist process to include expanded documentation requirements supporting revenue recognition methodology conclusions, additional levels of review and approval for revenue recognition checklists, and new system reporting capabilities to eliminate the need for certain manual control activities.

Table of Contents

Management has been testing the Company’s enhanced controls to determine whether they operate effectively over time. From this testing, management believes that the enhanced controls are operating effectively and the deficiencies that contributed to the material weakness have been remediated. Management will continue its evaluation of these controls through the end of the fiscal year, at which time our internal controls will be evaluated by Deloitte & Touche LLP in connection with their audit of the Company’s internal control over financial reporting.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended January 1, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II – OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

See Note 15 – “Commitments and Contingencies” to the financial statements for information regarding legal proceedings in which we are involved.

ITEM 1A. RISK FACTORS

There have been no material changes from the risk factors as previously disclosed in Part I, Item 1A “Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended March 31, 2020, except as described below.

Risks Relating to the Merger

The announcement and pendency of the Merger may result in disruptions to our business.

On January 27, 2021, we entered into the Merger Agreement with Parent and Merger Sub, affiliates of Veritas, pursuant to which we will be acquired by Peraton, a portfolio company of Veritas, in an all cash transaction. The Merger Agreement generally requires us to operate our business in the ordinary course pending consummation of the Merger and restricts us, without Veritas’s consent, from taking certain specified actions until the Merger is completed. These restrictions may affect our ability to execute our business strategies and attain financial and other goals and may impact our financial condition, results of operations and cash flows.

Further, in connection with the pending Merger, our current and prospective employees may experience uncertainty about their future roles with us following the Merger, which may materially adversely affect our ability to attract and retain key personnel while the Merger is pending. Key employees may depart because of issues relating to the uncertainty and difficulty of integration or a desire not to remain with us following the Merger, and may depart prior to the consummation of the Merger. Accordingly, no assurance can be given that we will be able to attract and retain key employees to the same extent that we have been able to in the past.

The proposed Merger further could cause disruptions to our business or business relationships, which could have an adverse impact on results of operations. Parties with which we have business relationships may experience uncertainty as to the future of such relationships and may delay or defer certain business decisions, seek alternative relationships with third parties or seek to alter their present business relationships with us. Parties with whom we otherwise may have sought to establish business relationships may seek alternative relationships with third parties.

The pursuit of the Merger may place a significant burden on management and internal resources. It may also divert management’s time and attention from the day-to-day operation of our remaining businesses and the execution of our other strategic initiatives. This could adversely affect our financial results. In addition, we have incurred and will continue to incur other significant costs, expenses and fees for professional services and other transaction costs in connection with the proposed Merger, and many of these fees and costs are payable regardless of whether or not the pending Merger is consummated.

Any of the foregoing could adversely affect our business, our financial condition and our results of operations and prospects.

The Merger may not be completed within the expected timeframe, or at all, and the failure to complete the Merger could adversely affect our business, results of operations, financial condition, and the market price of our common stock.

There can be no assurance that the Merger will be completed in the expected timeframe, or at all. The Merger Agreement contains a number of conditions that must be satisfied or waived prior to the completion of the Merger, including, among others, (i) adoption of the Merger Agreement by the affirmative vote of holders of a majority of outstanding shares of our common stock and (ii) the termination or expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. There can be no assurance that all required approvals will be obtained or that all closing conditions will otherwise be satisfied (or waived, if applicable), and, if all required approvals are obtained and all closing conditions are satisfied (or waived, if applicable), we can provide no assurance as to the terms, conditions and timing of such approvals or that the Merger will be completed in a timely manner or at all. Many of the conditions to completion of

Table of Contents

the Merger are not within our control, and we cannot predict when or if these conditions will be satisfied (or waived, as applicable). Even if regulatory approval is obtained, it is possible conditions will be imposed that could result in a material delay in, or the abandonment of, the Merger or otherwise have an adverse effect on us.

If the Merger is not completed within the expected timeframe or at all, we may be subject to a number of material risks. The price of our common stock may decline to the extent that current market prices reflect a market assumption that the Merger will be completed. In addition, some costs related to the Merger must be paid whether or not the Merger is completed, and we have incurred, and will continue to incur, significant costs, expenses and fees for professional services and other transaction costs in connection with the proposed transaction, as well as the diversion of management and resources towards the Merger, for which we will have received little or no benefit if completion of the Merger does not occur. We may also experience negative reactions from our investors, customers, partners, suppliers, and employees. In addition, if the Merger Agreement is terminated under certain specified circumstances, we will be required to pay Parent a termination fee of $97,013,974 (including in connection with our entry into an agreement with respect to a Company Superior Proposal, as defined in the Merger Agreement, if certain conditions are met).

Stockholder litigation could prevent or delay the closing of the pending Merger or otherwise negatively impact our business, operating results and financial condition.

We may incur additional costs in connection with the defense or settlement of any future stockholder litigation in connection with the pending Merger. Such litigation may adversely affect our ability to complete the pending Merger. We could incur significant costs in connection with any such litigation, including costs associated with the indemnification of obligations to our directors. Furthermore, one of the conditions to the closing of the Merger is the absence of any injunctions or restraints preventing the Merger or making the consummation of the pending Merger illegal. Consequently, if a plaintiff were to secure injunctive or other relief prohibiting, delaying or otherwise adversely affecting our ability to complete the Merger, then such injunctive or other relief may prevent the Merger from becoming effective within the expected time frame or at all.

The Merger Agreement contains provisions that could discourage a potential competing acquirer.

Under the terms of the Merger Agreement, we have agreed not to solicit or encourage discussions with third parties regarding other proposals to acquire us and are subject to restrictions on our ability to respond to any such proposal, except as permitted under the terms of the Merger Agreement. In the event that we receive an acquisition proposal or any inquiry that could reasonably be expected to lead to an acquisition proposal from a third party, we must notify Parent of such proposal and negotiate in good faith with Parent prior to effecting a change in the recommendation of our Board of Directors to our stockholders with respect to the pending Merger. The Merger Agreement also contains certain termination rights for both parties and further provides that, upon termination of the Merger Agreement under specified circumstances, including certain terminations in connection with an alternative business combination transaction as permitted by the terms of the Merger Agreement, we will be required to pay Parent a termination fee.

These provisions could discourage a potential third-party acquirer that might have an interest in acquiring all or a significant portion of Perspecta from considering or proposing that acquisition, even if it were prepared to pay consideration with a higher per share cash or market value than the market value proposed to be received or realized in the Merger. These provisions also might result in a potential third-party acquirer proposing to pay a lower price to our stockholders than it might otherwise have proposed to pay due to the added expense of the termination fee that may become payable in certain circumstances.

If the Merger Agreement is terminated and we determine to seek another business combination, we may not be able to negotiate a transaction with another party on terms comparable to, or better than, the terms of the pending Merger.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Unregistered Sales of Equity Securities

There were no sales of unregistered equity securities during the fiscal quarter ended January 1, 2021.

Use of Proceeds

Not applicable.

Table of Contents

Issuer Purchases of Equity Securities

On June 1, 2018, our Board of Directors authorized up to $400 million for future repurchases of outstanding shares of our common stock. Repurchases may be made at the Company’s discretion from time to time on the open market depending on market conditions. The repurchase program has no time limit, does not obligate the Company to make any repurchases and may be suspended for periods or discontinued at any time. No share repurchases were made under the Company’s share repurchase program during the fiscal quarter ended January 1, 2021. The total remaining authorization for future common stock repurchases under the share repurchase program was $275 million as of January 1, 2021.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS


Exhibit Number			Description of Exhibit
2.1			Agreement and Plan of Merger, dated as of January 27, 2021, by and among Perspecta Inc., Jaguar Parentco Inc. and Jaguar Merger Sub Inc. (incorporated by reference to Exhibit 2.1 to Perspecta Inc.’s Form 8-K (filed January 27, 2021) (file no. 001-38395))
3.1			Amendment to Bylaws of Perspecta Inc., effective January 26, 2021 (incorporated by reference to Exhibit 3.1 to Perspecta Inc.’s Form 8-K (filed January 27, 2021) (file no. 001-38395))
31.1			Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2			Certification of the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*			Certification of the Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*			Certification of the Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101			The following financial information from the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended January 1, 2021 formatted in Inline XBRL: (i) Condensed Consolidated Statements of Operations, (ii) Condensed Consolidated Statements of Comprehensive Income, (iii) Condensed Consolidated Balance Sheets, (iv) Condensed Consolidated Statements of Changes in Shareholders’ Equity, (v) Condensed Consolidated Statements of Cash Flows, and (vi) Notes to Condensed Consolidated Financial Statements.
104			The cover page from the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended January 1, 2021, formatted in inline XBRL (included as Exhibit 101).


* Furnished, not filed

Table of Contents

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


			Perspecta Inc.

Date:	February 5, 2021	By:	/s/ William G. Luebke
		Name:	William G. Luebke
		Title:	Senior Vice President, Principal Accounting Officer and Controller

Perspecta Inc. 10-Q